Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1050.Time spend outdoors in summer,45245,0.0405483110421236,0.0117779050213399,0.0174636172002974,0.0636330048839498,0.000576946348113996
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1060.Time spent outdoors in winter,42046,0.0318288248081333,0.0133757313084439,0.00561239144358324,0.0580452581726833,0.0173419205777422
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1070.Time spent watching television (TV),46288,0.0120598863277246,0.0116514672600976,-0.0107769895020667,0.0348967621575159,0.300655313273993
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1080.Time spent using computer,42053,-0.00356141254292623,0.0126068753184172,-0.028270888167024,0.0211480630811715,0.77756516871377
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1090.Time spent driving,41081,0.019882477411829,0.0132288796352574,-0.00604612667327541,0.0458110814969335,0.132867687687803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1160.Sleep duration,47806,0.00111841719265485,0.0109594373932844,-0.0203620800981826,0.0225989144834923,0.91871736396767
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32549,0.066095382323473,0.0389488622755268,-0.0102443877365596,0.142435152383506,0.0897365378202375
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32549,0.0309381980025055,0.0383364758277507,-0.0442012946198858,0.106077690624897,0.419678623489784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32549,-0.0764327132368135,0.044634301562426,-0.163915944299169,0.0110505178255414,0.0868547996501602
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32549,-0.0145791756723091,0.0461454050212987,-0.105024169514055,0.0758658181694364,0.752055697633814
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32549,-0.0176301943802365,0.0472629119512931,-0.110265501804771,0.0750051130442981,0.709139776722316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32549,-0.142341527036917,0.0905441280248425,-0.319808017965608,0.0351249638917742,0.115971189856072
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32549,0.0360710954020099,0.092875219904716,-0.145964335611233,0.218106526415253,0.697742625169896
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32549,-0.0171693871639583,0.0661190099169435,-0.146762646601168,0.112423872273251,0.795121409192994
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32549,0.0132997307505014,0.0497294302606937,-0.0841699525604582,0.110769414061461,0.789135329576343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32549,0.0335720947391,0.0347716733430815,-0.0345803850133398,0.10172457449154,0.334320671330628
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32549,0.119110750310934,0.0491073426237545,0.0228603587683757,0.215361141853493,0.015306786449337
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32549,-0.0149846056053791,0.0282259696584428,-0.0703075061359269,0.0403382949251688,0.595515436855979
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32549,0.000907446720051451,0.0361492482821809,-0.0699450799130231,0.071759973353126,0.979973557156453
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32549,0.0662677949350287,0.0546236920862501,-0.0407946415540214,0.173330231424079,0.225098017330281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32549,0.0383110576640235,0.0509364958912311,-0.0615244742827895,0.138146589610837,0.451991002924583
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32549,-0.0453752149397421,0.0628127321627672,-0.168488169978766,0.0777377400992815,0.470074905037262
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32549,0.0397237708549448,0.060547351405216,-0.0789490378992785,0.158396579609168,0.511791463721209
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32549,-0.0493588420168753,0.0403728225864059,-0.128489574286231,0.0297718902524802,0.221523061075
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32549,-0.0201430428629456,0.0379627840712175,-0.0945500996425319,0.0542640139166408,0.595709745110328
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32549,-0.0439316580447844,0.0470913244454639,-0.136230653957894,0.0483673378683249,0.35089575352969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120040.Fatigue severity over the past week,32558,0.00667252548604242,0.0184695266336074,-0.029527746715828,0.0428727976879128,0.717904791895952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32560,0.00381015517516056,0.0182145439627828,-0.0318903509918938,0.0395106613422149,0.834311043308387
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32558,-0.00527729206801215,0.0200225680275863,-0.0445215254020813,0.033966941266057,0.792119685335403
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120098.Mobility problems today,32562,-0.0374782027684068,0.0225280689133346,-0.0816332178385426,0.00667681230172899,0.0962239088459136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120099.Self-care problems today,32562,-0.0859945161076679,0.0349953859299554,-0.15458547253038,-0.0174035596849554,0.0140175535252526
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120100.Problems doing usual activities,32562,0.00207343231158732,0.0211837402427292,-0.0394466985641619,0.0435935631873365,0.92203104282699
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120101.Pain or discomfort today,32562,-0.00110781199345983,0.0184159437568741,-0.037203061756933,0.0349874377700133,0.952033528631724
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120102.Anxiety or depression today,32562,0.00480957013518507,0.0218749482427456,-0.0380653284205964,0.0476844686909665,0.825980221013896
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120103.Scale to indicate how health is today,32531,0.00754552463163506,0.012119894544644,-0.0162094686758671,0.0313005179391372,0.533581230510826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32546,-0.0203728304210886,0.0220291426340846,-0.0635499499838944,0.0228042891417172,0.355089051551916
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32532,0.00400431996157447,0.022420599967282,-0.0399400559742983,0.0479486958974472,0.858255939189615
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32551,0.012743637894356,0.0181776734750082,-0.02288460211666,0.0483718779053721,0.483284409745593
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32554,0.0147132504477748,0.0186079774120202,-0.0217583852797849,0.0511848861753345,0.42914307329811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32550,-0.0232115257985816,0.0228479126730597,-0.0679934346377786,0.0215703830406153,0.309698392889211
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32528,0.0109016896268766,0.0233381655841399,-0.0348411149180377,0.0566444941717908,0.640426820722091
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32554,-0.0222828032505175,0.0235838250821983,-0.068507100411626,0.0239414939105911,0.344769818499936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32542,-0.0547859684527289,0.0356016605737984,-0.124565223177374,0.014993286271916,0.123874949419186
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32498,0.00814940243647744,0.0462239813470089,-0.08244960100366,0.0987484058766148,0.860060449603667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30075,-0.024313801650579,0.0245082035038877,-0.072349880518199,0.023722277217041,0.32120304484328
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45132,0.00951821865456339,0.0260935577043114,-0.041625154445887,0.0606615917550137,0.715284678460121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43997,0.0125722038709292,0.0158416177745428,-0.0184773669671747,0.0436217747090332,0.427426802966648
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1289.Cooked vegetable intake,46919,5.83298527596354e-05,0.0113156445737042,-0.0221203335117005,0.0222369932172198,0.995887129722896
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46476,-0.0265824149680392,0.0120997390961142,-0.050297903596423,-0.00286692633965543,0.0280347559443002
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1309.Fresh fruit intake,46915,-0.00528525267486465,0.0120082413165141,-0.0288214056552322,0.0182509003055029,0.659843135387778
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1319.Dried fruit intake,45624,-0.00609748423428544,0.0126253488630292,-0.0308431680058226,0.0186481995372517,0.629132047325202
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X134.Number of self-reported cancers,48007,-0.054509652254326,0.0248690585651187,-0.103253007041959,-0.00576629746669333,0.0283986746978819
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48007,0.0125264352649713,0.0110172820232153,-0.00906743750053061,0.0341203080304732,0.255557703765848
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X136.Number of operations, self-reported",48007,0.00467416349023731,0.0109909411032028,-0.0168680810720402,0.0262164080525148,0.670640601844559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X137.Number of treatments or medications taken,48007,-0.00308779297069199,0.0109680842455576,-0.0245852380919849,0.018409652150601,0.778309954895927
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1438.Bread intake,47264,0.00423189264083612,0.00744811296295523,-0.0103664087665561,0.0188301940482284,0.569916030297705
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1458.Cereal intake,46588,0.00186203931615012,0.0113783402888103,-0.020439507649918,0.0241635862822183,0.870009940055039
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1488.Tea intake,47061,-0.00931566671519716,0.00707087220762025,-0.0231745762421329,0.00454324281173854,0.187693917424931
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1498.Coffee intake,46036,0.0140382332737902,0.0114177340435833,-0.00834052545163297,0.0364169919992134,0.218893200835285
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1528.Water intake,46307,-0.00979532155779406,0.0117181360534482,-0.0327628682225524,0.0131722251069643,0.403213740584178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1568.Average weekly red wine intake,40204,-0.0101237532641687,0.0132009175199579,-0.0359975516032862,0.0157500450749488,0.443153420012156
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,40198,0.000293985754553134,0.0135294351980588,-0.0262237072336421,0.0268116787427484,0.982664121362039
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,40240,-0.0245547792369272,0.0148699048930596,-0.053699792827324,0.00459023435346955,0.0986950578288311
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1598.Average weekly spirits intake,40173,0.00610756268100637,0.0149162884494179,-0.0231283626798526,0.0353434880418654,0.682210482003442
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1608.Average weekly fortified wine intake,40230,0.070167536567507,0.0269241871859615,0.0173961296830224,0.122938943451992,0.00916585617099543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1737.Childhood sunburn occasions,42368,-0.0179106336831951,0.0132875397914547,-0.0439542116744464,0.00813294430805613,0.177698360501131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1807.Father's age at death,38314,0.000296033904263661,0.00994782512677936,-0.0192017033442239,0.0197937711527512,0.976259942874268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1845.Mother's age,37596,0.0179805848481411,0.0152424906585626,-0.0118946968426416,0.0478558665389238,0.238165601358105
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1873.Number of full brothers,47572,0.00666681041576978,0.0110334446319342,-0.0149587410628213,0.0282923618943608,0.545692171432625
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1883.Number of full sisters,47573,0.000861906784402811,0.0110272679950859,-0.0207515384859655,0.0224753520547711,0.937700320140889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20015.Sitting height,47803,-0.0183476941633425,0.0094501049256061,-0.0368698998175305,0.000174511490845408,0.0522053306735279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20016.Fluid intelligence score,31568,0.014556851321366,0.0181222695604041,-0.0209627970170261,0.050076499659758,0.421850648215967
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20018.Prospective memory result,31865,-0.0345682557457091,0.0259716638116137,-0.0854727168164718,0.0163362053250537,0.183227287214904
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31490,-0.00509491921643229,0.0133009526509413,-0.0311647864122772,0.0209749479794127,0.701693958653029
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31494,-0.0146112436520332,0.0131402893613892,-0.040366210800356,0.0111437234962897,0.266197973050709
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20023.Mean time to correctly identify matches,47735,0.00234963125597027,0.00751143298103868,-0.0123727773868655,0.0170720398988061,0.754429782265464
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45226,0.00745350790932793,0.0163068199408952,-0.0245078591748268,0.0394148749934826,0.647618780495237
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44854,-0.0599769594059432,0.0372774059448403,-0.13304067505783,0.0130867562459439,0.107645378532208
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44827,-0.0201704156421312,0.0496447512809592,-0.117474128152811,0.0771332968685489,0.684529984326478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44853,0.0216215414681408,0.0380219451630681,-0.0529014710514727,0.0961445539877543,0.569593300135495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44856,0.0496388454904663,0.027746022712997,-0.00474335902700791,0.10402105000794,0.0736221976725185
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#2.Illnesses of father_Stroke,44991,0.0216659775717894,0.021395373519451,-0.0202689545263345,0.0636009096699133,0.311240022091235
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44939,-0.0230496360875355,0.0280068736752319,-0.07794310849099,0.0318438363159191,0.410517729039635
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44857,-0.0773295566899248,0.0338659454236735,-0.143706809720325,-0.0109523036595247,0.0224166612174743
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44975,0.0193143039440707,0.0265971271239198,-0.0328160652188121,0.0714446731069536,0.46773643027341
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45091,0.0246720498800773,0.0169257181156268,-0.00850235762655123,0.0578464573867057,0.144947320038509
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44965,0.00423330042934968,0.0229279401095574,-0.0407054621853828,0.0491720630440822,0.853517098804394
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46097,0.00300694703398519,0.0195156136914543,-0.0352436558012652,0.0412575498692356,0.877548812347602
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45992,0.027512377573543,0.0314697118496738,-0.0341682576518177,0.0891930127989036,0.381991920023723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45943,-0.0498730514681527,0.0677725087027961,-0.182707168525633,0.0829610655893276,0.461805998053052
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45984,0.0590923125590595,0.0283797562463458,0.00346799031622172,0.114716634801897,0.0373357188975639
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46043,0.0105189571079771,0.0232173989089841,-0.0349871447536318,0.0560250589695859,0.650507414443944
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45985,-0.0515095229704776,0.037879810763504,-0.125753952066946,0.0227349061259903,0.173902430362719
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45965,-0.00844565021766722,0.0354659292407372,-0.0779588715295121,0.0610675710941776,0.811779227328527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45995,-0.010776332909756,0.0271829216440827,-0.064054859332158,0.042502193512646,0.691786035417687
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46002,-0.00106061361006612,0.031819149648109,-0.0634261469203598,0.0613049197002276,0.973409692127266
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46194,-0.000292955017634309,0.0153446313974742,-0.0303684325566837,0.0297825225214151,0.984768127451704
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46048,0.00950315707640641,0.0237658772594089,-0.0370779623520351,0.0560842765048479,0.689259350154894
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43659,-0.00665460332007257,0.0315316021770494,-0.0684565435870893,0.0551473369469442,0.832853924832078
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43566,-0.0492918294077224,0.178192560288682,-0.398549247573539,0.299965588758095,0.782073930625065
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43565,-0.147699074222971,0.152429392187283,-0.446460682910046,0.151062534464103,0.33257347071795
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43642,0.00360882831124231,0.0287766648128039,-0.0527934347218532,0.0600110913443379,0.900201710272967
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43569,0.0140703936217782,0.0981637775666185,-0.178330610408794,0.206471397652351,0.886026368042166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43583,-0.0164906084711022,0.0539045703264483,-0.122143566310941,0.0891623493687365,0.759667058837139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43570,0.125298570424164,0.0708158055265643,-0.0135004084079016,0.264097549256231,0.0768494727846791
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43581,0.0964829054310352,0.0649726683072132,-0.0308635244511026,0.223829335313173,0.137565951915584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43583,-0.044356943539374,0.0431109555203023,-0.128854416359166,0.0401405292804185,0.303538398536567
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43587,-0.0394246614660147,0.0564862483913041,-0.150137708312971,0.0712883853809414,0.485215755629794
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43743,0.016271897113429,0.0202306345712088,-0.0233801466461404,0.0559239408729983,0.421222003031056
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43648,-0.0231705183892272,0.0294710401406196,-0.0809337570648416,0.0345927202863872,0.431752056166022
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20127.Neuroticism score,43194,0.00983849274833467,0.0114262538940084,-0.0125569648839218,0.0322339503805912,0.389225198076383
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,31568,0.0126570394504222,0.0183932457776036,-0.0233937222736809,0.0487078011745252,0.491388397284925
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X20161.Pack years of smoking,30629,-0.00144473986491074,0.0151489024861221,-0.03113658873771,0.0282471090078886,0.924024341897636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30629,0.000239451805211968,0.0141540440560388,-0.0275024745446242,0.0279813781550481,0.98650288726593
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20191.Fluid intelligence score,30052,0.0642022969431902,0.0204577717791284,0.0241050642560986,0.104299529630282,0.00170739804397172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30052,0.0507121359136957,0.0209842256050304,0.00958305372783605,0.0918412180995554,0.0156916075195584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20240.Maximum digits remembered correctly,29510,0.0306596479054127,0.0218654653529543,-0.0121966641863778,0.0735159599972032,0.16091201653053
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20255.Spirometry QC measure,41791,0.0358208316118362,0.0147733736638945,0.00686501923060296,0.0647766439930694,0.0153313337733328
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X20261.avMSE,29134,-0.0254298632037013,0.0163810438633339,-0.0575367091758358,0.00667698276843314,0.120627556726412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X20262.Myopia diagnosis,29134,0.00152348491498254,0.0268157514017255,-0.0510353878323994,0.0540823576623645,0.954696262301332
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X20280.Glucose-lactate,37139,0.0829615787400425,0.00985045448134481,0.0636546879566067,0.102268469523478,4.07453340281002e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,37166,0.0931049747626119,0.00972543405857515,0.0740431240078046,0.112166825517419,1.21517364144952e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31347,0.0236823025910947,0.0464263577143474,-0.0673133585290261,0.114677963711215,0.609993159935573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31345,0.00178910174373749,0.0931898113621387,-0.180862928526054,0.184441132013529,0.98468329031855
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31346,-0.0638801725540997,0.104804484750588,-0.269296962665251,0.141536617557052,0.542199943381736
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31346,0.0724335362455874,0.0449516105243242,-0.0156716203820881,0.160538692873263,0.107141939777355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31346,0.0346643520466735,0.0710182168752269,-0.104531353028771,0.173860057122118,0.625489712591242
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31350,0.0404220203654587,0.0926371195078816,-0.141146733869989,0.221990774600907,0.66259684911121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31350,-0.0123732095770008,0.0618708046032112,-0.133639986599295,0.108893567445293,0.841498035886802
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31350,0.0589929973708616,0.0674577037609408,-0.0732241020005823,0.191210096742305,0.381864090804047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31350,0.0113287450736141,0.104656178647606,-0.193797365075694,0.216454855222922,0.913802452873236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31350,-0.014033208817337,0.120310135992349,-0.24984107536234,0.221774657727666,0.907146920867612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31350,0.0415126318821639,0.0703508239625403,-0.0963749830844151,0.179400246848743,0.555154649126199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31350,0.0284675845762648,0.118232842678409,-0.203268787073416,0.260203956225946,0.809735625618008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31350,0.0310935341000162,0.0887109480841964,-0.142779924145009,0.204966992345041,0.725970413459556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31353,0.155524581381921,0.121784210205495,-0.0831724706208491,0.39422163338469,0.201624005030594
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31353,0.0398838399799328,0.0603026382502036,-0.0783093309904662,0.158077010950332,0.508379617344308
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31353,-0.0408061571625186,0.0815771792058556,-0.200697428405996,0.119085114080958,0.616938141884515
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31353,0.257471057421271,0.140339420650572,-0.0175942070538501,0.532536321896392,0.0666000005264859
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20600.Liking for adding salt to foods,33290,-0.0213574793011482,0.0163711095334056,-0.0534448539866232,0.0107298953843268,0.192066578681522
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20601.Liking for aniseed,33290,0.0117725482308835,0.0163252621198553,-0.020224965524033,0.0437700619857999,0.470850746801996
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20602.Liking for apple juice,33290,0.03549722435416,0.0163812134874175,0.0033900459188218,0.0676044027894982,0.0302638606510371
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20603.Liking for apples,33290,0.0130392573691454,0.0166991624831463,-0.0196911010978215,0.0457696158361122,0.434920333434043
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20604.Liking for asparagus,33290,-0.0103032517846588,0.016626727209774,-0.0428916371158157,0.0222851335464982,0.53548341375885
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20605.Liking for aubergine,33290,-0.0192983016972386,0.0164831317972759,-0.0516052400198993,0.0130086366254221,0.241712425386531
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20606.Liking for avocados,33290,-0.00211643991050242,0.0166154503163993,-0.034682722530645,0.0304498427096402,0.898644085484098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20607.Liking for bacon,33290,0.00762543506618378,0.0165065515027704,-0.0247274058792461,0.0399782760116137,0.644117695208091
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20608.Liking for baked or steamed fish,33290,0.000497155806197726,0.016618545578866,-0.0320751935283796,0.0330695051407751,0.976134900002637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20609.Liking for bananas,33290,0.00823485232589981,0.017004709264453,-0.025094377832428,0.0415640824842276,0.628206281908034
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33290,-0.0170531292636737,0.016531769769754,-0.0494553980123916,0.0153491394850441,0.302315629772023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20611.Liking for beef steak,33290,0.00584826991772558,0.0165739678326795,-0.0266367070343263,0.0383332468697774,0.72420221533106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20612.Liking for beetroot,33290,0.00545522891881602,0.0167960688186072,-0.0274650659656541,0.0383755238032862,0.745345705150181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20613.Liking for bell pepper,33290,-0.00803024081977505,0.0165377475288212,-0.0404442259762647,0.0243837443367145,0.627283073403643
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20614.Liking for bicycling,33290,0.0423175337544224,0.0164035867872134,0.0101665036514841,0.0744685638573607,0.00990152887170845
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20615.Liking for biscuits,33290,0.0245807883563087,0.0165616455078953,-0.007880036839166,0.0570416135517834,0.137789419296207
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20616.Liking for bitter foods,33290,-0.0215114501547319,0.0163863158900436,-0.0536286292992173,0.0106057289897535,0.189292722093417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20617.Liking for bitter or ale,33290,-0.00206548200673078,0.0168010138055027,-0.034995469065516,0.0308645050520544,0.902158865059427
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20618.Liking for black olives,33290,-0.012197755761477,0.0164734199531316,-0.0444856588696149,0.020090147346661,0.459045001919059
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20619.Liking for black pepper,33290,-0.00760455252696567,0.0165902843694012,-0.040121509890992,0.0249124048370607,0.64669444813567
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20620.Liking for blue cheese,33290,0.0158325899372957,0.0163935296143288,-0.0162987281067888,0.0479639079813802,0.334177636633254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20621.Liking for bolognese sauce,33290,-0.00279123101385601,0.0165852873514929,-0.035298394222782,0.02971593219507,0.866354341800407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20622.Liking for broad beans,33290,-0.000821563468762186,0.0164149088657325,-0.0329947848455978,0.0313516579080735,0.960083737043946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20623.Liking for broccoli,33290,0.00918899697106341,0.016983031431522,-0.0240977446347196,0.0424757385768465,0.588472608976143
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20624.Liking for brown rice,33290,0.0114370051584115,0.0165372150254969,-0.0209759362915624,0.0438499466083854,0.489210646536469
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20625.Liking for brussel sprouts,33290,0.029454935972168,0.0166231592531041,-0.00312645616391617,0.0620363281082521,0.0764398782685731
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20626.Liking for burgers (meat),33290,-0.00744338363373092,0.0164707093533248,-0.0397259739662475,0.0248392066987857,0.651339615090303
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20627.Liking for burn of spicy foods,33290,-0.0256202503827556,0.0164458211478095,-0.0578540598324621,0.00661355906695101,0.119300555925697
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20628.Liking for butter on bread,33290,0.0284814685141867,0.016729168045983,-0.00430770085594001,0.0612706378843135,0.088693996253275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20629.Liking for butternut squash,33290,-0.0129306233573357,0.0164790679118839,-0.0452295964646281,0.0193683497499567,0.432667050517058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20630.Liking for cabbage,33290,-0.00162893957247105,0.0166290535130088,-0.0342218844579683,0.0309640053130262,0.921968169739548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20631.Liking for cake,33290,0.0137070376902769,0.016609099252383,-0.0188467968443937,0.0462608722249475,0.409237631885679
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20632.Liking for cake icing,33290,0.00430882138900811,0.0163520628187036,-0.0277412217356508,0.0363588645136671,0.792168496295663
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20633.Liking for capers,33290,-0.00785917485015591,0.0163808436335428,-0.0399656283718999,0.024247278671588,0.631396115629612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20634.Liking for cauliflower,33290,0.0064857428950767,0.0167385685505607,-0.0263218514640222,0.0392933372541756,0.698414843999116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20635.Liking for cereal or granola bar,33290,0.0176780496597135,0.0163680703308395,-0.0144033681887319,0.0497594675081589,0.280155308683656
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20636.Liking for cheesecake,33290,0.056759719661226,0.0165223228615516,0.0243759668525848,0.0891434724698672,0.000594373270933196
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20637.Liking for cherries,33290,0.0142931015893626,0.0171691464944477,-0.0193584255397548,0.0479446287184801,0.405154875616754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20638.Liking for chicken,33290,-0.0145869014299133,0.0172381952906582,-0.0483737641996033,0.0191999613397767,0.397464597166677
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20639.Liking for chilli pepper,33290,-0.0167878683578316,0.0164573738194559,-0.0490443210439652,0.015468584328302,0.307715837069383
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20640.Liking for chips or french fries,33290,0.00676465471705487,0.0165542385033803,-0.0256816527495704,0.0392109621836802,0.682816232258863
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20641.Liking for cigarette smoking,33290,-0.0449957073535803,0.0258809554050615,-0.0957223799475009,0.00573096524034031,0.0821440840905282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20642.Liking for cod,33290,0.0128603913215571,0.0168849072288884,-0.0202340268470641,0.0459548094901783,0.446287928792727
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20643.Liking for coffee with sugar,33290,-0.00412580245180781,0.0180031397427657,-0.0394119563476286,0.031160351444013,0.818740773975981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20644.Liking for coffee without sugar,33290,0.013554633164056,0.0167142429281832,-0.0192052829751832,0.0463145493032951,0.417407385508553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20645.Liking for coriander,33290,0.0167940434550847,0.0164656559466369,-0.0154786422003235,0.049066729110493,0.307781312551197
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20646.Liking for corn flakes,33290,0.00722017522581297,0.0164410939619589,-0.0250043689396264,0.0394447193912524,0.660559890912381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20647.Liking for cream,33290,0.00740128213214161,0.0163540499410141,-0.024652655752246,0.0394552200165292,0.650871919765269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20648.Liking for croissant,33290,0.022703147368225,0.0164738408278425,-0.00958558065434624,0.0549918753907962,0.16819488839551
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20649.Liking for cucumber,33290,-0.000441024016317281,0.0165677685041149,-0.0329138502843825,0.032031802251748,0.978763865539453
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20650.Liking for curry,33290,-0.0223222153768075,0.0167207085381436,-0.0550948041115689,0.0104503733579539,0.181907244685164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20651.Liking for dairy products,33290,0.0324125633824796,0.0167308164754011,-0.000379836909306652,0.0652049636742658,0.0527388816102618
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20652.Liking for dark chocolate,33290,0.0140908813991032,0.0165693629455791,-0.0183850699742319,0.0465668327724383,0.39511444836312
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33290,0.0221263604966779,0.0168863175778259,-0.0109708219558608,0.0552235429492167,0.19012193507683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20654.Liking for dried fruit,33290,0.000446674374807414,0.0165793408020842,-0.0320488335972775,0.0329421823468924,0.978506864618181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20655.Liking for eggs,33290,0.00748586692607737,0.0169579373439947,-0.0257516902681521,0.0407234241203069,0.658906538454289
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20656.Liking for exercising alone,33290,0.0307486332909853,0.0164628995663043,-0.00151864985897113,0.0630159164409418,0.0618275037376772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20657.Liking for exercising with others,33290,0.0278640605640931,0.0164333395263594,-0.00434528490757137,0.0600734060357576,0.0899982745732223
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33290,-0.00855689515147895,0.0166897900125516,-0.04126888357608,0.0241550932731221,0.608171541186197
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20659.Liking for fatty foods,33290,-0.0271371801938236,0.0164032701354063,-0.05928758965922,0.00501322927157281,0.098084405785167
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20660.Liking for fresh tomatoes,33290,0.00725087419636458,0.0175541913351473,-0.0271553408205241,0.0416570892132533,0.679574562648698
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20661.Liking for fried chicken,33290,-4.0451391459299e-05,0.0163476714560115,-0.0320818874452417,0.0320009846623231,0.998025734038706
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20662.Liking for fried or battered fish,33290,0.00231484250644701,0.0164675177087188,-0.0299614922026418,0.0345911772155358,0.888212484690378
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20663.Liking for fruit,33290,0.0354588858247873,0.0181043761730849,-2.56914744590706e-05,0.0709434631240337,0.0501913462711342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20664.Liking for garlic,33290,-0.0211675798300655,0.0167830041577235,-0.0540622679792036,0.0117271083190726,0.207249679418487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20665.Liking for gherkins,33290,-0.011245120563862,0.0163318519949512,-0.0432555504739664,0.0207653093462423,0.491130238070273
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20666.Liking for globe artichoke,33290,-0.00857175354496972,0.016516462571767,-0.040944020185633,0.0238005130956936,0.603785198329921
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20667.Liking for goat's cheese,33290,0.00657212973593009,0.0163793858782694,-0.025531466585478,0.0386757260573382,0.688249614821489
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20668.Liking for going to a cafe,33290,0.0135299239351202,0.0165625042232368,-0.018932584342424,0.0459924322126644,0.414005743018238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20669.Liking for going to the gym,33290,0.0200512253934357,0.016308658879678,-0.0119137460107331,0.0520161967976045,0.218921321937176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20670.Liking for going to the pub,33290,-0.00592417141253228,0.016412180731647,-0.0380920456465604,0.0262437028214959,0.718136046511064
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20671.Liking for grapefruit,33290,0.0131148869851337,0.0164061301824621,-0.0190411281724921,0.0452709021427595,0.424084793667705
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20672.Liking for green olives,33290,-0.00599101070708228,0.0165046430665439,-0.0383401111175084,0.0263580897033438,0.716620936108679
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20673.Liking for haddock,33290,0.0101826190340885,0.0167653406444755,-0.0226774486290835,0.0430426866972605,0.543625805747511
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20674.Liking for ham,33290,0.0354268384832324,0.0165650762701806,0.00295928899367848,0.0678943879727864,0.0324899679691986
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20675.Liking for hard cheese,33290,0.0320885515145374,0.0169104172105135,-0.00105586621806897,0.0652329692471438,0.0577844542631116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20676.Liking for herring,33290,0.0149060733188413,0.0162915739143574,-0.0170254115532991,0.0468375581909817,0.360238146029144
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20677.Liking for honey,33290,0.0078506578903075,0.0164615387239354,-0.0244139580086059,0.0401152737892208,0.633437901665044
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33290,-0.016138250975266,0.0163666402817301,-0.048216865927457,0.015940363976925,0.324136139148314
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20679.Liking for ice cream,33290,0.0269352126178823,0.0164740527387676,-0.00535393075010214,0.0592243559858667,0.102080720786948
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20680.Liking for jam,33290,0.0192592992175871,0.0164342544790811,-0.0129518395614118,0.0514704379965861,0.241266930114069
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20681.Liking for kiwi fruit,33290,0.0108513120669049,0.0164994429715311,-0.021487596157296,0.0431902202911058,0.510761464695074
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20682.Liking for lager,33290,-0.0372273562222267,0.0165628855869772,-0.0696906119727019,-0.00476410047175141,0.0246223780803243
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20683.Liking for lamb,33290,0.00424853995522143,0.0166930437478993,-0.0284698257906613,0.0369669057011042,0.799107440204058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20684.Liking for lemons,33290,-0.0150077686387729,0.0165278079860667,-0.0474022722914636,0.0173867350139178,0.363884857971071
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20685.Liking for lentils or beans,33290,-0.00962300791308912,0.016611153495196,-0.0421808687636733,0.0229348529374951,0.562393846801536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20686.Liking for liver,33290,0.0306980019524005,0.0164540185632763,-0.00155187443162113,0.0629478783364221,0.062116621601634
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20687.Liking for mackerel,33290,0.00540501453650326,0.0163636762513815,-0.0266677909162045,0.037477819989211,0.74117637739826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20688.Liking for marzipan,33290,-0.000711751290850481,0.0162958007547847,-0.0326515207702285,0.0312280181885275,0.96516281820418
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20689.Liking for mayonnaise,33290,0.00521849505319302,0.0164217029875548,-0.0269680428024145,0.0374050329088005,0.750658575592398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20690.Liking for melon,33290,-0.0183700206706678,0.0169987665019476,-0.051687603014485,0.0149475616731494,0.279872546195097
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20691.Liking for milk chocolate,33290,0.0508680426781427,0.0166807195042003,0.0181738324499101,0.0835622529063753,0.00229850499443923
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20692.Liking for mushrooms,33290,-0.00522770919233052,0.01698888986436,-0.0385259333264761,0.0280705149418151,0.758307218865158
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20694.Liking for orange juice,33290,0.00897179520325331,0.0164732932793853,-0.0233158596243419,0.0412594500308485,0.586023184607129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20695.Liking for oranges,33290,-0.00352274603738421,0.0167307793293367,-0.0363150735228842,0.0292695814481157,0.833239232873788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20696.Liking for pasta,33290,-0.00750880989657626,0.0166155137493693,-0.0400752168453401,0.0250575970521876,0.651340188194326
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20697.Liking for pears,33290,0.0136643835865567,0.0167053715301398,-0.0190781446125173,0.0464069117856308,0.413398736009704
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20698.Liking for pizza,33290,-0.00895848534932895,0.0164625431349916,-0.0412250698939124,0.0233080991952545,0.586334728602972
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20699.Liking for plain yogurt,33290,0.0127165180636822,0.0164436056998085,-0.0195129491079426,0.0449459852353069,0.439339871215996
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20700.Liking for plums,33290,0.000411081611392279,0.0167087899881811,-0.0323381467654426,0.0331603099882271,0.980372374128465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20701.Liking for pollock,33290,0.00320449196943462,0.0163534982916155,-0.0288483646821318,0.035257348621001,0.844652379958461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20702.Liking for pork chop,33290,0.00643860856945093,0.0163490525082039,-0.0256055343466287,0.0384827514855306,0.693721734222772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20703.Liking for porridge,33290,0.0268929118253178,0.0167091370888463,-0.00585699686882094,0.0596428205194565,0.107546369621675
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20704.Liking for potato crisps,33290,0.00748238109335168,0.0166007103929283,-0.0250550112767877,0.0400197734634911,0.652197009933414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20705.Liking for potatoes,33290,-0.00488278621394387,0.0167549144011209,-0.0377224184401409,0.0279568460122532,0.770733383572374
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20706.Liking for prawns,33290,-0.00929097604872857,0.0166164588657727,-0.0418592354256431,0.0232772833281859,0.57607744641187
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20707.Liking for raw carrots,33290,-0.000179280478906317,0.0166297354204709,-0.0327735619030294,0.0324150009452167,0.991398626878514
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20708.Liking for red meat,33290,-0.00921357772813106,0.0165650277133152,-0.0416810320462288,0.0232538765899666,0.57808283826154
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20709.Liking for red wine,33290,-0.0120819486138825,0.0165750217964888,-0.0445689913350004,0.0204050941072355,0.466065629516269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33290,0.0217064901177701,0.0169989009378212,-0.0116113557203595,0.0550243359558996,0.201656697771093
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20711.Liking for roast chicken,33290,-0.00524746638853866,0.017290578540529,-0.0391370003279755,0.0286420675508982,0.761525429227358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20712.Liking for salad dressing,33290,-0.0177678326428653,0.0165126181545846,-0.0501325642258511,0.0145968989401205,0.28194789039208
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20713.Liking for salad leaves,33290,-0.00620833007057063,0.0169248515504636,-0.0393810391094794,0.0269643789683381,0.713763464637025
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20714.Liking for salami,33290,-0.0185475606459065,0.0163917646163511,-0.0506754192939546,0.0135802980021417,0.257866345173872
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20715.Liking for salmon,33290,-0.0207441455655311,0.017083137997348,-0.0542270960403331,0.0127388049092709,0.224661587052884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20716.Liking for salty foods,33290,0.00559286936938644,0.0163473472570675,-0.0264479312544659,0.0376336699932388,0.732262928016487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20717.Liking for salty pretzels,33290,-0.0100659421651742,0.0164285351252392,-0.042265871010643,0.0221339866802945,0.540082318345614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20718.Liking for sardines,33290,0.0208932711437538,0.0163186216982329,-0.0110912273847827,0.0528777696722902,0.200459541272806
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20719.Liking for sausages (meat),33290,0.0213615934985374,0.0164927685637096,-0.0109642328863335,0.0536874198834082,0.195279643794323
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20720.Liking for savoury biscuits,33290,0.00675800076382636,0.0165799743191119,-0.025738748901633,0.0392547504292857,0.683576482765277
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33290,-0.0103102154730805,0.0164111269670309,-0.042476024328461,0.0218555933823,0.529858404728481
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20722.Liking for skimmed milk,33290,-0.00984192964508412,0.0163414478613515,-0.0418711674533331,0.0221873081631648,0.547010312728573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20723.Liking for smoked fish,33290,0.00724729223828402,0.0163820011172622,-0.02486142995155,0.039356014428118,0.658214574561291
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20724.Liking for soft cheese,33290,0.0314708767173857,0.0163568120324929,-0.000588474866300454,0.0635302283010718,0.054381835735665
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20725.Liking for soy sauce,33290,0.0121296531907677,0.016449322280873,-0.0201110184797433,0.0443703248612788,0.460900347919352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20726.Liking for soya milk,33290,-0.0160062233014697,0.0165566110314058,-0.0484571809230251,0.0164447343200858,0.333690229725386
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20727.Liking for spicy foods,33290,-0.0133887440821728,0.0165124969525719,-0.0457532381092137,0.0189757499448682,0.417486701522545
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20728.Liking for spinach,33290,-0.00322885727411889,0.0165884046680065,-0.0357421304234116,0.0292844158751739,0.845674726848754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20729.Liking for spirits,33290,0.000890067247454357,0.0164166503776974,-0.0312865674928325,0.0330667019877412,0.956763148876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20730.Liking for strawberries,33290,0.0177232587971361,0.0178445645969544,-0.0172520878128945,0.0526986054071667,0.320636989889005
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33290,0.00161460881395304,0.016875902770172,-0.031462160615584,0.0346913782434901,0.923780411019166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20732.Liking for sweet foods,33290,0.0349643132781131,0.0164623475500982,0.00269811207992059,0.0672305144763055,0.0337048253665714
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20733.Liking for taking the stairs,33290,0.034883984435111,0.0168922432975739,0.00177518757186606,0.0679927812983559,0.0389418820684131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20734.Liking for tea with sugar,33290,0.000304806970835816,0.0198694469806301,-0.0386393091111992,0.0392489230528708,0.987760868055013
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20735.Liking for tea without sugar,33290,0.00836288063189548,0.0172846503583893,-0.0255150340705475,0.0422407953343385,0.628515786784999
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20736.Liking for tomato ketchup,33290,0.0119170058298451,0.0165330459932729,-0.0204877643169698,0.04432177597666,0.47105097097512
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20737.Liking for tinned tuna,33290,0.00202619441671456,0.01649442916638,-0.0303028867493902,0.0343552755828193,0.902235519381982
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20738.Liking for turnip (white),33290,6.53939520735088e-06,0.0164309615358857,-0.0321981452151287,0.0322112240055434,0.999682456570372
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20739.Liking for vegetables,33290,0.0246816147367009,0.0182435889467366,-0.0110758195989028,0.0604390490723046,0.176122439855626
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20740.Liking for vinegar,33290,-0.0293905135270724,0.0164222457964319,-0.0615781152880789,0.00279708823393405,0.0735379795187488
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20741.Liking for watching television,33290,-0.0186094354136632,0.0166094912234155,-0.0511640382115576,0.0139451673842311,0.262567765248543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20742.Liking for whisky,33290,0.00760549126801239,0.0170922947544884,-0.0258954064507849,0.0411063889868097,0.656354495283164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20743.Liking for white bread,33290,0.00949610828277252,0.0163485376508073,-0.0225470255128098,0.0415392420783548,0.561352966066767
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20744.Liking for white rice,33290,-0.00491946296308487,0.0165410932297731,-0.0373400056934401,0.0275010797672703,0.766161155374342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20745.Liking for white wine,33290,0.0166270824740423,0.016472287709377,-0.0156586014363367,0.0489127663844213,0.312810064231935
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33290,0.0370212135849924,0.0165524946924112,0.00457832398786653,0.0694641031821183,0.0253361822164222
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20747.Liking for whole milk,33290,0.0125250145858225,0.0163181888094267,-0.0194586354806539,0.0445086646522989,0.442774222260532
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20748.Liking for wholemeal bread,33290,0.0255980197616843,0.0171042606588105,-0.00792633112958433,0.0591223706529528,0.134534168206307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20749.Liking for working up a sweat,33290,0.0223075986441536,0.0164605900308856,-0.00995515781638208,0.0545703551046893,0.175382329636644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21001.Body mass index (BMI),47891,0.0877139968201943,0.0296140791904789,0.0296704016068556,0.145757592033533,0.00306044295180377
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21002.Weight,47909,-0.0234673817577993,0.0173750732829097,-0.0575225253923023,0.0105877618767037,0.176825098121716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,31799,-0.0123152605861625,0.0136632233323177,-0.0390951783175051,0.0144646571451801,0.367432935773842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32822,-0.0198578450857865,0.0175190555096159,-0.0541951938846336,0.0144795037130606,0.257034782744744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32823,-0.0161611253714905,0.0183935909188,-0.0522125635723385,0.0198903128293576,0.379626529433589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32823,-0.00898242590742935,0.018142659090576,-0.0445420377249583,0.0265771859100996,0.620541853757196
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21040.Satisfaction with bowel habits,32795,-0.0464797200668641,0.0168339513522247,-0.0794742647172245,-0.0134851754165037,0.00577300033581904
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32796,-0.0421013192046283,0.0177455115861968,-0.076882521913574,-0.00732011649568259,0.0176889807735256
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21042.Greatest number of times bowels opened per day,32787,0.00875201289254469,0.0183050115646016,-0.0271258097740744,0.0446298355591638,0.632575699737633
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21043.Least number of times bowels opened per week,32734,-0.0183580537798267,0.0180152315125626,-0.0536679075444494,0.0169517999847959,0.308216707825933
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21044.Average number of times bowels opened per day,32769,-0.000146140031906651,0.0201374544237638,-0.0396155507024837,0.0393232706386704,0.994209865150011
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32827,-0.00457215481375416,0.0182859172994274,-0.040412552720632,0.0312682430931236,0.802564509911963
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32821,0.00139527035085728,0.0183609378293554,-0.0345921677946792,0.0373827084963938,0.939427767670044
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29098,-0.0406628956696772,0.026798658571797,-0.0931882664703993,0.0118624751310448,0.129239160128583
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32824,-0.00791356274312871,0.0193723521446702,-0.0458833729466824,0.030056247460425,0.682918022700098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32822,0.0137966856154563,0.0275393585493013,-0.0401804571411743,0.067773828372087,0.616397049628174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32825,0.0321455292142903,0.0218387536130578,-0.0106584278673031,0.0749494862958837,0.141069784829484
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32823,0.068904818634858,0.0535775775724898,-0.0361072334072219,0.173916870676938,0.198449881783427
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32826,0.045146393224999,0.0206829615705634,0.00460778854669464,0.0856849979033033,0.0290777336846564
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32825,0.0176093481302339,0.0216320832749078,-0.0247895350885854,0.0600082313490532,0.41564453192665
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32607,0.00275047545481592,0.0191199372019541,-0.0347246014610141,0.0402255523706459,0.885619239949316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32825,0.0279587587017951,0.0189699231395782,-0.00922229065177806,0.0651398080553683,0.140557984996302
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32826,0.0439457800967055,0.0262063387518372,-0.00741864385689538,0.0953102040503064,0.0935941353319095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32825,0.0095949214080423,0.0182879251609311,-0.0262494119073826,0.0454392547234672,0.59983335655816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32825,-0.0193702511731015,0.0183371992249158,-0.0553111616539365,0.0165706593077335,0.290843015104027
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X21100.Water hardness (USGS classification),47693,0.0226262469523021,0.0112587276166946,0.000559140823580613,0.0446933530810235,0.0444781323256724
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2139.Age first had sexual intercourse,45338,-0.00375138904856435,0.00800438939064931,-0.019439992254237,0.0119372141571083,0.639312802307819
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2149.Lifetime number of sexual partners,43606,-0.000783791938468332,0.0126112346557845,-0.0255018118638059,0.0239342279868692,0.950443774823618
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22032.IPAQ activity group,43586,-0.00812803206665844,0.0121019984922089,-0.0318479491113878,0.015591884978071,0.501828886184007
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22033.Summed days activity,44087,0.000505196173474523,0.00773999720125563,-0.0146651983409865,0.0156755906879356,0.947958998558055
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22034.Summed minutes activity,43586,-0.000508671513024867,0.00789081782256332,-0.015974674445249,0.0149573314191992,0.948601643184453
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22037.MET minutes per week for walking,42917,-0.00582360151581798,0.00777258009035377,-0.0210578584929114,0.00941065546127541,0.453716105233569
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22038.MET minutes per week for moderate activity,43586,0.0092801595194729,0.0081017027889613,-0.00659917794689125,0.025159496985837,0.252033419013764
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22039.MET minutes per week for vigorous activity,43586,-0.00474704744806188,0.0120343884742679,-0.028334448857627,0.0188403539615033,0.693248013932726
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22040.Summed MET minutes per week for all activity,42917,-0.00139197802074161,0.00798723678317664,-0.0170469621157678,0.0142630060742846,0.861650967623442
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X2217.Age started wearing glasses or contact lenses,43101,-0.00461121444614976,0.00917959330962497,-0.0226032173330147,0.0133807884407152,0.615438910636796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X22501.Year ended full time education,30015,0.0776155493650709,0.0404581963693951,-0.00168251551894348,0.156913614249085,0.0551048112794686
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X22506.Tobacco smoking,29973,0.0952364227964305,0.0435848220595489,0.00981017155971463,0.180662674033146,0.0289206612856235
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46270,-0.0155879067193745,0.0248155014323452,-0.0642262895267712,0.0330504760880221,0.529910776202911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23098.Weight,47586,-0.0188140214735491,0.0175003660345299,-0.0531147389012276,0.0154866959541294,0.282356804408537
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23099.Body fat percentage,47564,0.0159081725421444,0.0169251119825761,-0.0172650469437048,0.0490813920279936,0.347270560950179
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23100.Whole body fat mass,47534,0.000186524097772251,0.0161011092748175,-0.03137165008087,0.0317446982764145,0.99075717114279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23101.Whole body fat-free mass,47583,-0.0225522647388818,0.0149428066796957,-0.0518401658310854,0.0067356363533218,0.131251066715402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23102.Whole body water mass,47586,-0.0216046561947565,0.0149437260302971,-0.0508943592141388,0.00768504682462584,0.148264968902139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23104.Body mass index (BMI),47586,0.0982998142023154,0.0298999396036678,0.0396959325791266,0.156903695825504,0.001011828755265
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23105.Basal metabolic rate,47584,-0.0255376930496976,0.0160156894856005,-0.0569284444414746,0.00585305834207952,0.110827963371837
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23106.Impedance of whole body,47583,-0.00200726087262403,0.0122451623373899,-0.0260077790539083,0.0219932573086602,0.869793341805737
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23107.Impedance of leg (right),47583,0.0384570236458058,0.0101055347813124,0.0186501754744335,0.0582638718171781,0.000141850040824279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23108.Impedance of leg (left),47582,0.0403696003383442,0.0100063812718919,0.020757093045436,0.0599821076312523,5.49167910411202e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23109.Impedance of arm (right),47577,-0.0327965152017341,0.0123002866455406,-0.0569050770269936,-0.00868795337647453,0.00767383855638149
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23110.Impedance of arm (left),47581,-0.0335743675550443,0.0122810834917978,-0.0576452911989679,-0.00950344391112061,0.00626491986270389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23111.Leg fat percentage (right),47582,0.0723730201459514,0.0208652172420349,0.031477194351563,0.11326884594034,0.000524112589268344
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23112.Leg fat mass (right),47581,0.0499136518560073,0.0216017351147808,0.00757425103103686,0.0922530526809778,0.0208617464698606
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23113.Leg fat-free mass (right),47581,-0.057785431574654,0.016054212722981,-0.0892516885116968,-0.0263191746376112,0.000319609757677092
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23114.Leg predicted mass (right),47580,-0.0589848555469416,0.0161282151470614,-0.0905961572351819,-0.0273735538587013,0.000255490689456941
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23115.Leg fat percentage (left),47579,0.0864436976295949,0.0215621461506899,0.0441818911742426,0.128705504084947,6.11502240093614e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23116.Leg fat mass (left),47579,0.053380348793777,0.0224709387495116,0.00933730884473421,0.0974233887428198,0.0175317518153769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23117.Leg fat-free mass (left),47577,-0.0590225784886784,0.016648311940833,-0.0916532698927111,-0.0263918870846457,0.000392982481605226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23118.Leg predicted mass (left),47576,-0.0589906447181595,0.0167143839135989,-0.0917508371888134,-0.0262304522475057,0.000417395511749179
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23119.Arm fat percentage (right),47576,0.000855823195702159,0.0186974737140545,-0.0357912252838447,0.037502871675249,0.963492258017886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23120.Arm fat mass (right),47575,0.00117306360300181,0.0182371726089331,-0.034571794710507,0.0369179219165107,0.94871384633998
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23121.Arm fat-free mass (right),47574,0.00242375925097995,0.01497035460032,-0.0269181357656472,0.0317656542676071,0.871382886910213
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23122.Arm predicted mass (right),47573,0.00826323993182972,0.0149712764979767,-0.0210804620042047,0.0376069418678641,0.580994957032502
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23123.Arm fat percentage (left),47570,-0.00470566304312535,0.0190992857275348,-0.0421402630690935,0.0327289369828428,0.805390988656852
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23124.Arm fat mass (left),47570,0.00162884116551894,0.0181536646950462,-0.0339523416367716,0.0372100239678095,0.928506349185172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23125.Arm fat-free mass (left),47566,0.00321090294108242,0.0151999659898246,-0.0265810303989738,0.0330028362811386,0.83269862608496
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23126.Arm predicted mass (left),47565,0.0126613977586,0.0152818142108959,-0.0172909580947559,0.042613753611956,0.40738037543321
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23127.Trunk fat percentage,47563,-0.0024546621331301,0.0121246582862898,-0.026218992374258,0.0213096681079978,0.839565064911266
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23128.Trunk fat mass,47559,-0.0101368972742716,0.013232786658338,-0.0360731591246141,0.0157993645760708,0.443657731285574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23129.Trunk fat-free mass,47555,-0.00820487727815897,0.0136117389553122,-0.0348838856305708,0.0184741310742529,0.546661151127554
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23130.Trunk predicted mass,47553,-0.00874627603147506,0.0135894902330787,-0.0353816768883093,0.0178891248253591,0.519837255693797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23400.Total Cholesterol,37169,0.126768741272132,0.0103216529901303,0.106538301411477,0.146999181132787,1.74310073154488e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37169,0.138640943850446,0.00999345504675364,0.119053771958808,0.158228115742083,1.84807397662467e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37169,0.144347293114097,0.0100277752797959,0.124692853565697,0.164001732662497,1.24989114015227e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23403.VLDL Cholesterol,37169,0.159757270991742,0.00984761987581467,0.140455936035145,0.179058605948338,1.26637880418707e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,37169,0.112891380814212,0.0100086931629033,0.0932743422149214,0.132508419413502,2.25617887052918e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23405.LDL Cholesterol,37169,0.127200979882633,0.00991304092071606,0.107771419678029,0.146630540087236,1.81693643504177e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23406.HDL Cholesterol,37169,-0.00660308434372482,0.0114162121470855,-0.0289788601520125,0.0157726914645628,0.563007000343199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23407.Total Triglycerides,37169,0.187989414364793,0.0100863391273162,0.168220189675253,0.207758639054332,1.4852053160921e-76
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23408.Triglycerides in VLDL,37169,0.186913296023692,0.0102502616013512,0.166822783285044,0.20700380876234,2.12685163781406e-73
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23409.Triglycerides in LDL,37169,0.163367160025062,0.00965626173555,0.144440887023384,0.18229343302674,1.5208351313734e-63
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23410.Triglycerides in HDL,37169,0.15841932157541,0.0095615050682734,0.139678771641594,0.177159871509226,4.8094242740686e-61
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37169,0.148549821587383,0.0102005365150093,0.128556770017964,0.168542873156801,1.12391339180856e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23412.Phospholipids in VLDL,37169,0.177039196560933,0.00993352704682573,0.157569483549154,0.196508909572711,3.09612470070801e-70
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23413.Phospholipids in LDL,37169,0.12556257948768,0.00992126005580938,0.106116909778293,0.145008249197066,1.6837232903867e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23414.Phospholipids in HDL,37169,0.0458541675587848,0.0107015235704123,0.0248791813607766,0.066829153756793,1.84167263887423e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23415.Total Esterified Cholesterol,37169,0.121245993314632,0.0103675916161605,0.100925513746958,0.141566472882307,1.93276925631829e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37169,0.148264284010159,0.00986424240972347,0.128930368887101,0.167598199133217,1.20653649868414e-50
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37169,0.137520501845223,0.00986405367712086,0.118186956638066,0.15685404705238,7.20087560416919e-44
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37169,-0.0173538454679024,0.0113902523150865,-0.039678740005472,0.00497104906966715,0.127639949058692
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23419.Total Free Cholesterol,37169,0.137744048687401,0.0101997701227409,0.117752499246829,0.157735598127973,2.74628697056806e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,37169,0.171877887280715,0.00988578276849638,0.152501753054462,0.191254021506968,5.74078214359079e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23421.Free Cholesterol in LDL,37169,0.0947304929216576,0.0100620100576789,0.0750089532086069,0.114452032634708,5.51502759895427e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23422.Free Cholesterol in HDL,37169,0.0294992335684909,0.0113161414560388,0.00731959631465478,0.0516788708223269,0.0091487168410235
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37169,0.166972268986648,0.00990247939161356,0.147563409379085,0.186381128594211,3.88997942853159e-63
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23424.Total Lipids in VLDL,37169,0.185186451357029,0.0100187790450594,0.165549644428713,0.204823258285346,2.43239414863999e-75
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23425.Total Lipids in LDL,37169,0.133327757373023,0.00989519945151766,0.113933166448048,0.152722348297997,4.13791027744615e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23426.Total Lipids in HDL,37169,0.0361712160176965,0.0109457029198989,0.0147176382946946,0.0576247937406984,0.00095361884442275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37169,0.0963568177536399,0.0102971155984216,0.0761744711807335,0.116539164326546,9.44076391783856e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23428.Concentration of VLDL Particles,37169,0.168519899931014,0.00981552015727458,0.149281480422755,0.187758319439272,2.29945181883318e-65
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23429.Concentration of LDL Particles,37169,0.129287154647395,0.00991320849680135,0.109857265993664,0.148717043301125,1.21895000435871e-38
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23430.Concentration of HDL Particles,37169,0.0786982200547892,0.0103062816209865,0.0584979080776556,0.0988985320319227,2.39423803128407e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37169,0.175142187324061,0.0107763245097387,0.154020591284973,0.196263783363149,7.89500115676939e-59
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,37169,-0.0490193533833955,0.00999001223273251,-0.0685997773595512,-0.0294389294072398,9.36527324200192e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,37169,-0.0858550710666761,0.0115421491414512,-0.10847768338392,-0.0632324587494317,1.08153210165673e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23434.Phosphoglycerides,37157,0.143071891234538,0.0100983345369094,0.123279155542196,0.162864626926881,3.08898475366941e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37157,0.154316304371316,0.010863451759751,0.133023938922204,0.175608669820428,1.83151403930343e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23436.Total Cholines,37157,0.139355437495202,0.0102763985532191,0.119213696330892,0.159497178659511,1.29412751948039e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23437.Phosphatidylcholines,37157,0.132514072409146,0.0102547037825091,0.112414852995428,0.152613291822864,5.70394753615627e-38
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23438.Sphingomyelins,37156,0.109242758035411,0.0106325871635423,0.0884028871948676,0.130082628875953,1.13737823627087e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23439.Apolipoprotein B,37169,0.134059646685718,0.00994511827097602,0.114567214874605,0.153552078496831,3.82096578772815e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23440.Apolipoprotein A1,37169,0.0574268131958555,0.0106317370099521,0.0365886086563493,0.0782650177353616,6.72402564233419e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37169,0.0853559729748635,0.00997396490738733,0.0658070017563843,0.104904944193343,1.27451015037874e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23442.Total Fatty Acids,37157,0.182276092918506,0.00962885448912584,0.16340353811982,0.201148647717193,6.9859745914267e-79
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23443.Degree of Unsaturation,37157,-0.0982447834082601,0.0107629874706785,-0.11934023885079,-0.0771493279657303,7.96931150661823e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,37157,0.0609470632370383,0.00990349457021172,0.0415362138794233,0.0803579125946532,7.76757664776954e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,37157,0.158154774325923,0.00980387717026342,0.138939175072207,0.177370373579639,5.40685599479946e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37157,0.149982423959988,0.00982565360438049,0.130724142895402,0.169240705024574,3.65449686119214e-52
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37157,0.192147101133269,0.00978504830021815,0.172968406464842,0.211325795801697,1.18084568738209e-84
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23448.Saturated Fatty Acids,37157,0.18343757929559,0.00967862135662414,0.164467481436607,0.202407677154573,4.59362673989911e-79
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23449.Linoleic Acid,37157,0.159363892179852,0.00987524313767555,0.140008415630008,0.178719368729696,4.92639330735866e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23450.Docosahexaenoic Acid,37157,0.0112399428923352,0.0103676949545154,-0.00908073921851502,0.0315606250031855,0.278326231014635
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37157,-0.0331518111720306,0.0100232173141145,-0.052797317107695,-0.0135063052363662,0.000943817701992878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37157,-0.14308070219536,0.0101575057786055,-0.162989413521427,-0.123171990869293,9.68051865171364e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37157,-0.165090064389986,0.0105284339547493,-0.185725794941295,-0.144454333838677,6.38791390714416e-55
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37157,0.160274746252914,0.0107742230818088,0.139157269012569,0.18139222349326,1.18694908966089e-49
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37157,0.0862091218224335,0.00975286831821695,0.0670934999187283,0.105324743726139,1.08243064129297e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37157,-0.0427242777511241,0.0104599921282296,-0.0632258623224541,-0.0222226931797941,4.44226371613034e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37157,-0.109312127120237,0.0104304914351612,-0.129755890333153,-0.0888683639073205,1.34222546801266e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37157,-0.171885866472544,0.0107515963463424,-0.192958995311375,-0.150812737633713,5.34321856673953e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37155,-0.00360819396367616,0.00994480986307886,-0.0231000212953107,0.0158836333679584,0.716743762485907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23460.Alanine,37166,0.081093547179042,0.00968440367558109,0.0621121159749031,0.100074978383181,6.14206577951861e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23461.Glutamine,37129,-0.0833673927059781,0.00959843666774571,-0.10218032857476,-0.0645544568371965,4.20706656222415e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23462.Glycine,37154,0.0518888815302899,0.0100253469615676,0.0322392014856174,0.0715385615749623,2.3028199950524e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23463.Histidine,37155,0.0513181496626281,0.00954424845099365,0.0326114226986806,0.0700248766265757,7.70747676676134e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37158,0.0871080932597893,0.0101863986650934,0.0671427518762063,0.107073434643372,1.3476845221366e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23465.Isoleucine,37168,0.0650424518855471,0.00993523135121914,0.0455693984371576,0.0845155053339366,6.10017026704143e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23466.Leucine,37169,0.079340798425708,0.0102393135126527,0.0592717439409088,0.0994098529105072,9.95881483145494e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23467.Valine,37158,0.0896950427827957,0.0101481868744738,0.0698045965088271,0.109585489056764,1.09046246904345e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23468.Phenylalanine,37165,0.0278899628108759,0.00963225993006875,0.00901073334794117,0.0467691922738107,0.00379201878247289
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23469.Tyrosine,37155,0.0593746984101272,0.00987626822954335,0.0400172126802222,0.0787321841400321,1.88216715713235e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23470.Glucose,37149,0.00439602819759909,0.00989664814178141,-0.0150014021602925,0.0237934585554907,0.656909820427991
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23471.Lactate,37147,0.138777650356128,0.00963353114000329,0.119895929321721,0.157659371390534,1.0709029826576e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23472.Pyruvate,37126,0.0434101207510031,0.00958332176916857,0.0246268100834327,0.0621934314185735,5.95666205738392e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23473.Citrate,37168,0.0552903391649268,0.00979307536353135,0.0360959114524053,0.0744847668774482,1.67717081898337e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23474.3-Hydroxybutyrate,36961,0.0223082407699382,0.00960856056269095,0.00347546206706396,0.0411410194728125,0.0202640954442673
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23475.Acetate,37159,-0.102947412883832,0.00957227615121508,-0.121709074140214,-0.0841857516274507,7.25905725542671e-27
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23476.Acetoacetate,37169,0.0269482673542438,0.00952138772173297,0.00828634741964715,0.0456101872888404,0.00465758160535709
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23477.Acetone,37169,-0.061158324720734,0.00956459125030082,-0.0799049235713237,-0.0424117258701444,1.66733291666408e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23478.Creatinine,36832,0.0723080275424034,0.0120858851294196,0.0486196926887409,0.0959963623960659,2.25045629000908e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23479.Albumin,37168,0.0757539559329009,0.00979531096868453,0.0565551464342792,0.0949527654315226,1.11956552396639e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23480.Glycoprotein Acetyls,37169,0.199348274016913,0.0101465787743782,0.179460979619132,0.219235568414694,9.72052523907811e-85
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37169,0.164528673479775,0.0102388595857813,0.144460508691643,0.184596838267906,1.46201398194856e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37169,0.159208515222932,0.0102893029084374,0.139041481522395,0.179375548923469,1.5385071542665e-53
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37169,0.164132814880473,0.0103011191751949,0.143942621297091,0.184323008463855,1.23800193919489e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37169,0.170251405738606,0.0102148797379468,0.15023024145223,0.190272570024982,9.61192455145221e-62
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37169,0.172285319921578,0.0102304293396973,0.152233678415771,0.192336961427385,5.5243005498605e-63
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37169,0.163545864962936,0.0101472687081581,0.143657218294946,0.183434511630926,6.81280454673924e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37169,0.148349095190919,0.0102799853984739,0.12820032380991,0.168497866571928,7.4679769753829e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37169,0.185544938773509,0.0103628383118906,0.165233775682203,0.205856101864814,7.31506064217251e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37169,0.184508909600672,0.0103769433417844,0.164170100650775,0.20484771855057,6.41090076490817e-70
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37169,0.18034852127898,0.0103176518393111,0.16012592367393,0.200571118884029,1.16564005879578e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37169,0.177012690316212,0.0101640278178501,0.157091195793225,0.196934184839198,3.4854101356666e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37169,0.169894617433722,0.0100757788690313,0.150146090850421,0.189643144017023,3.88850170714774e-63
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37169,0.178164997858131,0.0102403784760486,0.158093856045076,0.198236139671186,4.68500010693981e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37169,0.182516351152996,0.010480229484265,0.161975101363836,0.203057600942155,3.50353734812765e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37169,0.184964921893688,0.0102494552005476,0.164875989700614,0.205053854086761,6.06168320385209e-72
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,37169,0.184484023375897,0.0102555640810148,0.164383117777107,0.204584928974686,1.6758563085882e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,37169,0.182967394712519,0.010316604594915,0.162746849706486,0.203187939718553,1.41328386917515e-69
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,37169,0.177228400971011,0.0100821635893792,0.157467360335827,0.196989441606194,2.13312989156473e-68
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37169,0.166577609079048,0.00992582135762026,0.147122999218112,0.186032218939984,1.44554486622633e-62
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37169,0.184577969098835,0.010265786605001,0.164457027353033,0.204698910844637,1.95546570130759e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,37169,0.182670970476097,0.0103161878169934,0.162451242354789,0.202890698597404,2.29907639483575e-69
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37169,0.161362838529438,0.00982797819848963,0.142100001260399,0.180625675798478,5.45709772817764e-60
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37169,0.173100743191973,0.0098489568981153,0.153796787671667,0.192404698712279,2.24124220745595e-68
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37169,0.159055547475396,0.00983395134083225,0.139781002847365,0.178330092103427,2.75779800305258e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37169,0.115618230819187,0.00998248493122657,0.0960525603539828,0.135183901284391,7.13992234297627e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37169,0.0858273157616189,0.0101222787706223,0.0659876493711992,0.105666982152039,2.50771075651135e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37169,0.145559274270313,0.00984500267083178,0.126263069035483,0.164855479505143,4.47851371474435e-49
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37169,0.18724348064339,0.0100853916707775,0.167476112968666,0.207010848318114,5.52087091612855e-76
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37169,0.168533014392175,0.0098564552273757,0.149214362146519,0.187851666637831,7.46083855003678e-65
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,37169,0.171350812619393,0.00983008252903624,0.152083850862482,0.190617774376304,2.66678348989487e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,37169,0.156921075207847,0.00978329784830493,0.137745811425169,0.176096338990525,2.32534027341415e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,37169,0.142067901205642,0.00982232235135022,0.122816149396995,0.161319653014288,4.66572214928108e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37169,0.142617835666503,0.00983849756925004,0.123334380430773,0.161901290902233,2.94541046691325e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37169,0.138252219901898,0.00983347248176157,0.118978613837646,0.157525825966151,1.40652402537843e-44
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,37169,0.17324170273797,0.00996408958502412,0.153712087151323,0.192771318324617,5.71779317636426e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37169,0.13274258594083,0.00990618835612413,0.113326456762827,0.152158715118833,1.10987394123647e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37169,0.133399327748932,0.00987337168655045,0.114047519243293,0.152751136254571,2.52070199546053e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37169,0.126301294852502,0.00981650187419887,0.107060951179072,0.145541638525932,1.16899991929856e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37169,0.109440048425625,0.0102652790494948,0.0893201014886155,0.129559995362635,1.97642214889264e-26
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37169,0.102471291100335,0.0104070888393438,0.0820733969752214,0.122869185225449,8.50828113628146e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37169,0.121040972944146,0.00995641511369131,0.101526399321311,0.140555546566981,7.94857517091122e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37169,0.151495315478461,0.00970947255968056,0.132464749261487,0.170525881695435,2.11059706507896e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23523.Concentration of IDL Particles,37169,0.108355154728682,0.0102081022526922,0.0883472743134049,0.128363035143958,3.24369192185175e-26
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23524.Total Lipids in IDL,37169,0.114016763943864,0.010442228013615,0.0935499970371786,0.134483530850549,1.22737721767158e-27
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23525.Phospholipids in IDL,37169,0.109340764665813,0.0104383422237472,0.0888816139072681,0.129799915424357,1.41623340435199e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23526.Cholesterol in IDL,37169,0.100967903317834,0.0105193739050137,0.0803499304640071,0.121585876171661,9.55969039188496e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37169,0.104711702635569,0.0105048924805981,0.0841221133735968,0.125301291897541,2.54262809071253e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23528.Free Cholesterol in IDL,37169,0.0872789385454759,0.0105149679599225,0.0666696013440277,0.107888275746924,1.13649597728684e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23529.Triglycerides in IDL,37169,0.144940278727787,0.00958915391210679,0.126145537060057,0.163735020395516,3.4279003326702e-51
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,37169,0.115806327252231,0.00994867024847757,0.0963069335652151,0.135305720939247,3.63629523608852e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23531.Total Lipids in Large LDL,37169,0.125063240752219,0.00998688227466426,0.105488951493877,0.144637530010561,8.91727312326603e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23532.Phospholipids in Large LDL,37169,0.120468801249894,0.0100190938819951,0.100831377241183,0.140106225258604,3.94978000582043e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23533.Cholesterol in Large LDL,37169,0.117901527707157,0.010011342579537,0.0982792962512648,0.13752375916305,7.39845834170143e-32
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37169,0.125391917741529,0.00994714478852476,0.105895513956021,0.144888321527038,3.15841090656196e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37169,0.0939333064847298,0.0101987263940396,0.0739438027524121,0.113922810217047,3.73257166475397e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23536.Triglycerides in Large LDL,37169,0.153985792537485,0.00961185914873097,0.135146548605972,0.172825036468997,3.1533832625975e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37169,0.143777345346462,0.00984305298940738,0.124484961487224,0.163069729205701,5.95464079805589e-48
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,37169,0.146772098583675,0.00979590921416807,0.127572116523905,0.165972080643444,2.43877063071052e-50
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,37169,0.138531705615791,0.00979060460430814,0.119342120591347,0.157721290640235,3.99609500996359e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,37169,0.142568073593653,0.00980356296122494,0.123353090189652,0.161783056997654,1.50887844663116e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37169,0.154641220313636,0.00980248605527556,0.135428347645296,0.173854092981976,1.4560916160514e-55
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37169,0.101486996661947,0.00984931594805369,0.082182337403762,0.120791655920132,8.3799700815245e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,37169,0.170449565286689,0.00972488406623596,0.151388792516867,0.189510338056512,5.15364359758413e-68
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,37169,0.137975073491899,0.0098914140497576,0.118587901954374,0.157362245029424,6.50178107767868e-44
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23545.Total Lipids in Small LDL,37169,0.133038399142087,0.00988591186244934,0.113662011891686,0.152414786392487,5.16585158120519e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23546.Phospholipids in Small LDL,37169,0.101678470776499,0.00994232161520751,0.082191520410692,0.121165421142305,1.85174713272005e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23547.Cholesterol in Small LDL,37169,0.131680466268512,0.00986961173610197,0.112336027265753,0.151024905271272,2.39437270930985e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37169,0.149420879664779,0.00985510969579961,0.130104864661011,0.168736894668546,1.70451255270484e-51
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37169,0.0735181256331757,0.00989047514873342,0.0541327943416582,0.0929034569246932,1.12449884982651e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23550.Triglycerides in Small LDL,37169,0.180385103846085,0.00984354255616716,0.161091760435998,0.199678447256173,4.23412752194708e-74
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37169,-0.0436254205679538,0.0116579689601472,-0.0664750397298423,-0.0207758014060654,0.000183247566857021
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37169,-0.0754979908648496,0.011670960074499,-0.0983730726108676,-0.0526229091188316,1.02188103794172e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37169,-0.0811755259165227,0.0115260249868893,-0.103766534890826,-0.0585845169422197,1.97663343272102e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37169,-0.0865834663491853,0.0118617919918218,-0.109832578653156,-0.0633343540452145,3.05542741109537e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37169,-0.0881066706063103,0.0120099952710539,-0.111646261337576,-0.0645670798750446,2.32614144098938e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37169,-0.0768132742232365,0.0111465281445557,-0.0986604693865657,-0.0549660790599073,5.78021830750631e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37169,0.126266109644852,0.00941384532159491,0.107814972814526,0.144717246475178,9.35593095959321e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,37169,-0.0593411169301348,0.0119411391205526,-0.0827457496064179,-0.0359364842538516,6.79712077105819e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23559.Total Lipids in Large HDL,37169,-0.0589228840431853,0.0117586458282991,-0.0819698298666516,-0.035875938219719,5.48356222190096e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23560.Phospholipids in Large HDL,37169,-0.0475209119200538,0.0115046545823976,-0.0700700349015532,-0.0249717889385545,3.6405785804379e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23561.Cholesterol in Large HDL,37169,-0.085983003718073,0.012034440908624,-0.109570507898976,-0.06239549953717,9.48547582574021e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37169,-0.0932016665992733,0.012054084275387,-0.116827671779032,-0.0695756614195148,1.13488934687199e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37169,-0.0599001281150699,0.0118782909036071,-0.0831815782861398,-0.036618677944,4.64747408601253e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23564.Triglycerides in Large HDL,37169,0.104820091601911,0.00952173594339337,0.0861574891528605,0.123482694050962,4.59492027653345e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37169,0.0493168135804518,0.0105077665319357,0.0287215911778578,0.0699120359830457,2.71422179819777e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,37169,0.0582320674948475,0.0103342152974604,0.0379770055118251,0.0784871294778698,1.78733792522561e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,37169,0.0695187137488374,0.0101549436567654,0.0496150241815772,0.0894224033160975,7.93832701520116e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,37169,0.0217357632850426,0.0106739565827228,0.000814808382905791,0.0426567181871793,0.0417363712924698
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37169,0.0145434545732956,0.0106500979210047,-0.00633073735187363,0.0354176464984648,0.172097035690524
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37169,0.0497585621926207,0.0107034616220062,0.0287797774134886,0.0707373469717528,3.37032104868561e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,37169,0.157743207396534,0.00959856001491623,0.138930029767298,0.17655638502577,4.25986111175195e-60
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,37169,0.122024824588689,0.00953163476286529,0.103342820453473,0.140706828723905,2.6487171758549e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23573.Total Lipids in Small HDL,37169,0.141863284483254,0.00957031472149534,0.123105467629123,0.160621101337385,2.56218347072444e-49
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23574.Phospholipids in Small HDL,37169,0.140023519604294,0.00959155471066605,0.121224072371389,0.158822966837199,6.7187081560115e-48
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23575.Cholesterol in Small HDL,37169,0.107042524367477,0.00953296727540661,0.0883579085076805,0.125727140227274,3.98632773245669e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37169,0.0903922152770735,0.0095018356497163,0.0717686174036296,0.109015813150517,2.16354466157059e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37169,0.140624880438486,0.00967056390735799,0.121670575180064,0.159579185696907,1.52934079196463e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23578.Triglycerides in Small HDL,37169,0.184413198714272,0.0102956533938116,0.164233718062401,0.204592679366143,6.479463386343e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,0.0402309640763749,0.00972928372907799,0.0211615679673821,0.0593003601853678,3.57180870066064e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,-0.0181861619170421,0.00971214172293506,-0.0372219596939949,0.000849635859910578,0.0611579478318869
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,-3.24757417575603e-05,0.00962853445298373,-0.0189044032696057,0.0188394517860906,0.997308901683213
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,-0.0499184082615793,0.00983807133473302,-0.069201028077656,-0.0306357884455026,3.95044323568094e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36538,0.000938138345594375,0.00952473016621148,-0.0177303327801801,0.0196066094713689,0.921540795219373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37005,0.0481265307728345,0.00945438417657295,0.0295959377867515,0.0666571237589174,3.62259630288892e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37005,-0.102666928208097,0.010601328078707,-0.123445531242363,-0.0818883251738318,4.16589863306871e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37005,-0.103646718942961,0.0105576538626733,-0.124339720513801,-0.0829537173721211,1.13591530069974e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37005,-0.0694973138774321,0.010131372397517,-0.0893548037765655,-0.0496398239782988,7.21363461894349e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37005,0.0691992877073039,0.0102978178421458,0.0490155647366981,0.0893830106779097,1.8947305138229e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37165,0.113523562284088,0.0102466254360003,0.0934401764295271,0.133606948138648,2.10870420677517e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37165,-0.0277659992893631,0.00988773898202395,-0.0471459676941301,-0.00838603088459616,0.00499035772228198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37165,-0.0558629742902824,0.010314471155399,-0.0760793377548645,-0.0356466108257002,6.2013077810085e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37165,0.0345743796148781,0.00963618683862717,0.0156874534111689,0.0534613058185874,0.000334455213734274
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37165,-0.027315349782901,0.00948889487433631,-0.0459135837366002,-0.00871711582920186,0.00399998567772504
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37169,-0.0166721264399966,0.010417316697904,-0.0370900671678884,0.00374581428789515,0.109528230250545
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37169,-0.087981588718446,0.0108444259794268,-0.109236663638123,-0.0667265137987694,5.36583253288222e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37169,-0.0991534390539444,0.0108754541317719,-0.120469329152217,-0.0778375489556714,8.80175635821563e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37169,-0.0530909939544004,0.0106443658885598,-0.0739539510959777,-0.0322280368128231,6.18700842225301e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37169,0.0727656809344801,0.0107830494139342,0.051630904083169,0.0939004577857912,1.55935237808814e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37169,-0.0573575429420072,0.0103736746519177,-0.0776899452597659,-0.0370251406242486,3.27858378289711e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37169,-0.04941290232155,0.0100080581380828,-0.0690286962721923,-0.0297971083709077,8.01670192531766e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37169,-0.0371057323758837,0.00971904517510984,-0.056155060919099,-0.0180564038326684,0.000135237036077774
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37169,-0.062100654636493,0.01044753924196,-0.0825778315507345,-0.0416234777222515,2.85030356800372e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37169,0.0525425409565647,0.0101198024381306,0.0327077281778287,0.0723773537353006,2.11053967527595e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37169,-0.0290840406489635,0.0101146797178509,-0.0489088128959513,-0.0092592684019757,0.00404119262669407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37169,-0.0579741480903547,0.010642584635547,-0.0788336139760268,-0.0371146822046825,5.20270634567416e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37169,-0.0570702177047252,0.0107640795043737,-0.0781678135332977,-0.0359726218761526,1.16427456352606e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37169,-0.0471066793350612,0.00968092232879296,-0.0660812870994955,-0.028132071570627,1.15225810444465e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37169,0.0732800846694988,0.0105270203001367,0.0526471248812307,0.0939130444577668,3.53343890196918e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37169,-0.054661755021255,0.00975909875551662,-0.0737895885820675,-0.0355339214604424,2.17207732581009e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37169,-0.0206316682073161,0.01022886646892,-0.0406802464863993,-0.000583089928232774,0.0437150990032601
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37169,0.00626135645570977,0.0101228589213782,-0.0135794470301916,0.0261021599416111,0.536232413527773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37169,-0.0704200779451255,0.00996597185836152,-0.0899533827875141,-0.0508867731027369,1.67336213321739e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37169,0.0489281074781967,0.0103171961937787,0.0287064029383904,0.069149812018003,2.13408908406267e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37169,-0.0602158807687469,0.00974214236559114,-0.0793104798053056,-0.0411212817321883,6.55696456558241e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37169,-0.00705371813551587,0.0102439780169048,-0.0271319150486493,0.0130244787776176,0.491104543798437
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37169,0.0792211419386012,0.0095957834121402,0.0604134064508064,0.098028877426396,1.64976832555427e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37169,-0.111491160994648,0.0107799410829157,-0.132619845517162,-0.0903624764721328,5.62891356446482e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37169,0.0337462219462384,0.0100026662246828,0.0141409961458601,0.0533514477466167,0.000743706015925091
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37169,-0.107547056763614,0.00963431206094653,-0.126430308403069,-0.0886638051241585,8.31306624212964e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37169,0.0344917206650557,0.0100331222273066,0.0148268010995348,0.0541566402305767,0.000588286863957429
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37169,0.145243512362031,0.00991944273517691,0.125801404601084,0.164685620122978,3.57319571834144e-48
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37169,-0.144808419875491,0.0104204960384532,-0.165232592110859,-0.124384247640123,1.34079211908026e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37169,0.0289418702856521,0.00977374821034113,0.00978532379338352,0.0480984167779207,0.00306999385471112
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37169,-0.170436430129753,0.00977718864287318,-0.189599719869784,-0.151273140389721,2.63145889267757e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37169,0.0688822045898722,0.00968517880533569,0.0498992541314142,0.0878651550483301,1.20106598458451e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37169,0.167637143726487,0.00979519550825009,0.148438560530316,0.186835726922657,5.75310081719689e-65
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37169,-0.113640596243139,0.00994911555313999,-0.133140862727294,-0.0941403297589848,4.47316122477456e-30
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37169,0.0995907363821672,0.0100154686058979,0.0799604179146073,0.119221054849727,3.23742291034704e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37164,-0.092798761534895,0.0109173910853792,-0.114196848062238,-0.0714006750075517,2.09465965964332e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37164,2.55753243896829e-05,0.0100501116076338,-0.0196726434265725,0.0197237940753519,0.997969599564331
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37164,-0.0199736484810242,0.00959052987895585,-0.0387710870437777,-0.00117620991827073,0.0373028453649718
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37164,0.0428853339670396,0.0115656093594582,0.0202167396225015,0.0655539283115777,0.000209747518014705
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37164,0.177168472575267,0.0106697448196447,0.156255772728763,0.19808117242177,2.66189565843846e-61
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37169,0.0916877992334092,0.0107927828115783,0.0705339449227158,0.112841653544103,2.18245483504838e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37169,-0.146455008400935,0.0109876880485455,-0.167990876976084,-0.124919139825786,2.84383446639967e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37169,-0.146190703578477,0.0106060495396781,-0.166978560676246,-0.125402846480708,6.29712887263325e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37169,-0.0349664617142424,0.0108230860270786,-0.0561797103273165,-0.0137532131011683,0.00123774837681003
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37169,0.149182532285212,0.0103833820006692,0.128831103563901,0.169533961006524,1.8436144458629e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37169,0.0862118445650085,0.0108775994961543,0.064891749552546,0.107531939577471,2.44968572460337e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37169,-0.127997514390988,0.0106245214800577,-0.148821576491901,-0.107173452290075,2.98205696028769e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37169,-0.139307342505801,0.0101344925644046,-0.159170947932034,-0.119443737079568,1.05530562579941e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37169,0.0112250474104596,0.0115400160038153,-0.0113933839570184,0.0338434787779375,0.330716921963556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37169,0.143336037577368,0.010300487795194,0.123147081498788,0.163524993655948,1.03254745711048e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37169,0.00171603956669475,0.00962134006434194,-0.0171417869594154,0.0205738660928049,0.858444824058723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37169,-0.0794957317705246,0.00961474806064989,-0.0983406379693983,-0.0606508255716508,1.48928971260462e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37169,-0.079440118770894,0.0094254219118628,-0.0979139457181451,-0.0609662918236429,3.8654266415155e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37169,0.0143972038444272,0.0105291755969624,-0.00623998032561915,0.0350343880144735,0.17153468328679
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37169,0.139806994895124,0.0105411313158333,0.119146377516091,0.160467612274157,6.7951205573829e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47609,0.00396256874838151,0.0081329229909957,-0.0119779603139701,0.0199030978107331,0.62610292197899
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47609,-0.00207157912052834,0.00795947617697692,-0.0176721524274031,0.0135289941863464,0.794661038199405
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45866,-0.00109759603676168,0.0076766161285884,-0.016143763648795,0.0139485715752716,0.886307958194367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45866,-0.0042302052045335,0.00831365075460079,-0.020524960683551,0.012064550274484,0.610878995509478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45866,-0.0116361737792697,0.00823960138897155,-0.0277857925016539,0.00451344494311454,0.157897765574649
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45866,-0.0095513718013882,0.00761332961423097,-0.0244734978452809,0.0053707542425045,0.209652190157929
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24009.Traffic intensity on the nearest road,47609,-0.0774549759472912,0.0243647140190221,-0.125209815424574,-0.0297001364700079,0.00147983081722609
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24010.Inverse distance to the nearest road,47609,-0.00446960714799726,0.00711723737642892,-0.018419392405798,0.00948017810980343,0.530011628341174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24011.Traffic intensity on the nearest major road,47609,0.0023765192621497,0.00718194907856083,-0.0117001009318295,0.0164531394561289,0.740721646333136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24012.Inverse distance to the nearest major road,47609,-0.00375698067864502,0.00729047933868745,-0.0180463201824724,0.0105323588251824,0.606329347292138
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24013.Total traffic load on major roads,47609,-0.0128036010053241,0.0168395664868513,-0.0458091513195527,0.0202019493089045,0.447065845495244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24015.Sum of road length of major roads within 100m,47609,-0.0223849749812054,0.0163755017763993,-0.054480958462948,0.00971100850053721,0.171644675450514
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47609,0.0168767534103607,0.00816475320072171,0.000873837136946106,0.0328796696837752,0.0387425574638421
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47609,0.0123668258335414,0.00816244767194677,-0.00363157160347423,0.0283652232705571,0.129763449936601
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47609,0.0170364375747188,0.00807797422348469,0.00120360809668878,0.0328692670527488,0.0349551293448523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47562,0.0410188520517433,0.00780155699495596,0.0257278003416296,0.056309903761857,1.47070255080558e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24020.Average daytime sound level of noise pollution,47609,-0.0142129400350369,0.0071365145559659,-0.02820050856473,-0.000225371505343703,0.0464285876042448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24021.Average evening sound level of noise pollution,47609,-0.0141399211705196,0.00713592655065145,-0.0281263372097964,-0.000153505131242749,0.0475454431809826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24022.Average night-time sound level of noise pollution,47609,-0.0142382416266934,0.00713673129817035,-0.0282262349711072,-0.000250248282279465,0.046047215743345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47609,-0.0142160389329302,0.00713648618342387,-0.028203551852441,-0.000228526013419409,0.0463800520918665
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47609,-0.0141855049465423,0.00713690098562507,-0.0281738308783675,-0.00019717901471719,0.0468643009268785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2405.Number of children fathered,34487,-0.0178984219777042,0.0181069849245729,-0.053388112429867,0.0175912684744586,0.322939331777553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44769,-0.0064998431636411,0.00852283225601792,-0.0232045943854362,0.010204908058154,0.445687399673021
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44769,-0.00109424841234252,0.00777035625272236,-0.0163241466676784,0.0141356498429933,0.888010770044785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24502.Water percentage, buffer 1000m",44769,-0.0133889216798388,0.00756743314130824,-0.0282210906368029,0.00144324727712534,0.0768614343955826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44769,-0.00793556441935709,0.00804669633116785,-0.0237070892284461,0.0078359603897319,0.324051726001937
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44769,0.00117067315945642,0.0078853967351813,-0.0142847044414989,0.0166260507604118,0.881980466556096
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24505.Water percentage, buffer 300m",44769,-0.0102092719146335,0.00759293193258782,-0.0250914185025056,0.00467287467323861,0.17877687456844
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47694,-0.0127217376152404,0.00800117967004759,-0.0284040497685337,0.00296057453805285,0.111851957731848
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47694,-0.00931787647701802,0.0075471980285527,-0.0241103846129813,0.00547463165894528,0.216986361460014
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24508.Distance (Euclidean) to coast,47694,0.0484253408272756,0.00720170193992412,0.0343100050250244,0.0625406766295269,1.80610349507046e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28016,-0.00747542906698071,0.0278990798549232,-0.0621576255826301,0.0472067674486687,0.788754672773433
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2704.Years since last cervical smear test,33866,0.0257138471896926,0.0168652027419237,-0.00734195018447778,0.0587696445638631,0.127373350005674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2714.Age when periods started (menarche),36732,0.00439481364824489,0.0150409366385552,-0.0250854221633232,0.033875049459813,0.770145945554103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2734.Number of live births,37148,-0.000902592076268812,0.0142845961069458,-0.0289004004458826,0.027095216293345,0.949619032350494
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2744.Birth weight of first child,33869,-0.00527736132014813,0.0163945863817388,-0.0374107506283561,0.0268560279880598,0.747537770317667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2754.Age at first live birth,32151,-0.00577552082938797,0.0121470669155937,-0.0295837719839516,0.0180327303251756,0.634467180092874
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2764.Age at last live birth,32127,0.000403702316515461,0.0121552781128819,-0.023420642784733,0.0242280474177639,0.973506250453486
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2794.Age started oral contraceptive pill,35166,-0.00480675552951777,0.0120403911409996,-0.028405922165877,0.0187924111068415,0.689739224019744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2804.Age when last used oral contraceptive pill,34149,-0.00691736755845753,0.0107036799390727,-0.0278965802390401,0.014061845122125,0.518124955354382
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2867.Age started smoking in former smokers,28572,0.0111382407389666,0.015744558327863,-0.0197210935836448,0.041997575061578,0.479331608326487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34264,-0.027113718338629,0.019669045660376,-0.0656650478329659,0.0114376111557079,0.168079571928666
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34258,-0.0122779902603688,0.0217800846269948,-0.0549669561292786,0.030410975608541,0.572953083364734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34277,-0.0300852077508886,0.0225471618795057,-0.0742776450347197,0.0141072295329424,0.182127034291213
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34252,0.00467076747384831,0.0218729488712395,-0.038200212313781,0.0475417472614776,0.830909342126188
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28739.Difficulty with standing for long periods,34292,-0.0297415154472998,0.020654506599103,-0.0702243483815416,0.010741317486942,0.149910758187414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28740.Difficulty with taking care of household responsibilities,34310,-0.0335582361531487,0.0230469212886632,-0.0787302018789286,0.0116137295726312,0.145399656782324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28741.Difficulty learning a new task,34232,-0.00361148687798348,0.0256670515589747,-0.0539189079335739,0.0466959341776069,0.88810559304189
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28742.Difficulty with joining in community activities,33848,-0.0274074308907212,0.0248241987899297,-0.0760628605189833,0.021247998737541,0.269593262790186
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,34235,-0.0216449755177346,0.021364264334054,-0.0635189336124804,0.0202289825770113,0.311017268618623
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,34308,-0.0681134963733612,0.0292391961158627,-0.125422320760452,-0.0108046719862703,0.0198501278624821
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28440,-0.0130255349657208,0.0268663677234164,-0.065683615703617,0.0396325457721753,0.627822405071669
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2897.Age stopped smoking,28572,0.013832416551517,0.0189711475203809,-0.0233510325884297,0.0510158656914636,0.465958907461276
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,33134,-0.00506695363096816,0.0235581655610597,-0.0512409581306452,0.0411070508687088,0.829707578523821
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,33134,-0.0166806774837244,0.0252686538307444,-0.0662072389919833,0.0328458840245346,0.509184745033494
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,33134,0.114484214047501,0.0850918632393145,-0.0522958379015551,0.281264265996558,0.17852283997701
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,33134,0.0665375400153529,0.0844979904489173,-0.0990785212645249,0.232153601295231,0.431041398776461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,33134,0.151565286596056,0.0907768970472861,-0.0263574316166251,0.329488004808736,0.0950231652398668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,33134,0.130758872762198,0.0770380571494299,-0.0202357192506848,0.281753464775081,0.0896681668800981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,33134,0.00217420492291522,0.0349899351369301,-0.0664060679454677,0.0707544777912982,0.950454267299936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,33134,0.00788191271468921,0.0633914558726708,-0.116365340795745,0.132129166225124,0.901051031816664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,33083,-0.0031792956254747,0.0227932910412423,-0.0478541460663097,0.0414955548153603,0.889070875841461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29003.Recent feelings of depression,33082,0.0127322025236114,0.0220064959109778,-0.030400529461905,0.0558649345091279,0.56289642267154
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",33088,0.0242254244511272,0.0180409168092573,-0.011134772495017,0.0595856213972715,0.179368317142827
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29005.Recent feelings of tiredness or low energy,33095,0.00139210301023326,0.0182980994444645,-0.0344721719009171,0.0372563779213836,0.939357812899883
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29006.Recent poor appetite or overeating,33097,-0.0328914276773243,0.0241574580023047,-0.0802400453618415,0.014457190007193,0.173375241115502
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29007.Recent feelings of inadequacy,33064,0.00683607415403355,0.0235147686335998,-0.039252872367822,0.0529250206758891,0.771276559416812
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29008.Recent trouble concentrating on things,33095,-0.0326707575588574,0.0236962419008142,-0.0791153916844533,0.0137738765667385,0.168010923357637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,33085,-0.0685357850054903,0.0421930344810747,-0.151234132588397,0.0141625625774161,0.104337681837991
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29010.Recent thoughts of suicide or self-harm,33032,0.0191049393336187,0.0456762970800992,-0.0704206029433757,0.108630481610613,0.675760883368727
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#0.Substances taken for depression_None of options listed,31456,0.00341492317593703,0.0446043334432258,-0.0840095703727855,0.0908394167246596,0.93897532239609
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31456,-0.137766738479134,0.0786102440385817,-0.291842816794755,0.0163093398364856,0.0797232170545922
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31456,-0.0344842484508602,0.0444346270033417,-0.12157611737741,0.0526076204756894,0.437733579048672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31456,-0.108163526706647,0.12968380397855,-0.362343782504606,0.146016729091312,0.404275777526808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31456,-0.0554141623203358,0.0769496369208622,-0.206235450685226,0.0954071260445541,0.471463753353416
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31456,-0.0500197333656908,0.0821661319396974,-0.211065351967498,0.111025885236116,0.542699484494781
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31456,-0.0752461702456801,0.0966405600338597,-0.264661667912045,0.114169327420685,0.436228473327606
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31456,-0.0174532233832643,0.113246339232994,-0.239416048279933,0.204509601513404,0.877521318794677
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31456,-0.0569597956959684,0.0893382858497769,-0.232062835961531,0.118143244569594,0.523770042027946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31456,-0.0238398386916521,0.0454055666768608,-0.112834749378299,0.065155071994995,0.59956917762706
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31456,-0.130359945880969,0.0666347613103275,-0.260964078049211,0.000244186287272463,0.0504622422732555
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31456,-0.0290658981729323,0.104541985622511,-0.233968189993054,0.175836393647189,0.780996236571182
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31456,0.107818322035671,0.129637460853309,-0.146271101236815,0.361907745308158,0.405609470946807
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31456,0.0150342661979661,0.0824246126197166,-0.146517974536678,0.176586506932611,0.855273532787323
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31456,0.0256000096399881,0.134316395265447,-0.237660125080287,0.288860144360263,0.848848139542915
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31456,0.115965674367804,0.127103621116531,-0.133157423020597,0.365088771756204,0.361602336864969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31456,-0.0643873063101783,0.0687092055714572,-0.199057349230234,0.0702827366098777,0.348737589554049
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31456,0.0667366268547541,0.0678361562298948,-0.0662222393558397,0.199695493065348,0.325249424094909
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31456,0.0428184141911782,0.0971947775198081,-0.147683349747646,0.233320178130002,0.659556893841508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29058.Recent feelings or nervousness or anxiety,32948,-0.00375812863918474,0.0209826752079586,-0.0448841720467836,0.0373679147684141,0.857858254362202
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29059.Recent inability to stop or control worrying,32950,0.00260596321653841,0.0219449323576234,-0.0404061042044035,0.0456180306374803,0.905475956850801
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29060.Recent worrying too much about different things,32946,0.0108585084978668,0.020170029361528,-0.028674749050728,0.0503917660464616,0.59034954613689
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29061.Recent trouble relaxing,32950,-5.97989321745568e-05,0.0211809673328337,-0.0415744949045286,0.0414548970401795,0.997747446181455
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29062.Recent restlessness,32952,0.0167661653599595,0.0296732626935748,-0.0413934295194471,0.0749257602393662,0.572070013572182
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29063.Recent easy annoyance or irritability,32938,-0.00913423279169327,0.0214394493406798,-0.0511555534994257,0.0328870879160392,0.670083031775034
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29064.Recent feelings of foreboding,32932,0.00148132826777706,0.024429908741514,-0.0464012928655904,0.0493639494011445,0.951650558286611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31456,-0.0277789551260168,0.0456452616248692,-0.11724366791076,0.0616857576587268,0.542818712001018
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31456,-0.0930574975524717,0.0736251761053161,-0.237362842718891,0.0512478476139479,0.206291847881825
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31456,-0.098930506072237,0.0980540354568638,-0.29111641556769,0.0932554034232161,0.31303619554544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31456,0.0941836113072894,0.107995514101891,-0.117487596332417,0.305854818946995,0.383177736404038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31456,-0.0442990712539319,0.0689615207944328,-0.17946365201102,0.0908655095031564,0.520649920908551
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31456,-0.0732696942195564,0.0742544729800671,-0.218808461260488,0.0722690728213751,0.323802630113131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31456,-0.0881630109637994,0.073813549288377,-0.232837567569018,0.0565115456414196,0.232358261016159
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31456,-0.0510081593478186,0.0685325323933941,-0.185331922838871,0.0833156041432338,0.45672336026468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31456,-0.117677790335001,0.0898403853732594,-0.29376494566659,0.0584093649965871,0.190284834689399
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29076.Felt loved as a child,32911,0.0320372851056583,0.0187805661379109,-0.00477262452464709,0.0688471947359638,0.0880658060181683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29077.Physically abused by family as a child,32913,-0.0434040524884401,0.0242403729995198,-0.0909151835674989,0.00410707859061867,0.0733959503602414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29078.Felt hated by family member as a child,32902,-0.0315976871236104,0.0246897852552486,-0.0799896662238976,0.0167942919766768,0.200652604848444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29079.Sexually molested as a child,32838,0.0344225516247647,0.0335453475726906,-0.0313263296177088,0.100171432867238,0.304848635807419
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29080.Someone to take to doctor when needed as a child,32900,0.00964291740038899,0.0282179876500637,-0.0456643383937358,0.0649501731945138,0.732562452865996
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32898,-0.0525132865784269,0.0340260082232378,-0.119204262695973,0.0141776895391193,0.122786260763088
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32852,0.015609668908274,0.0267515798755028,-0.0368234276477115,0.0680427654642594,0.55956832301156
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32907,-0.00595537145438548,0.0294400627502552,-0.0636578944448857,0.0517471515361147,0.839696128621615
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32873,0.0519581106066533,0.0414941872158495,-0.0293704963364118,0.133286717549718,0.210537486327787
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32874,0.0437362833430297,0.0402195655811304,-0.0350940651959858,0.122566631882045,0.27687237078687
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29086.Experienced a violent or sexual assault,32909,-0.0161046714146848,0.0323284146078859,-0.0794683640461412,0.0472590212167716,0.618384506284337
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29087.Experienced a life-threatening injury or illness,32915,-0.0135877220881193,0.0228199328064044,-0.058314790388672,0.0311393462124334,0.551569509914118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29088.Experienced a marital separation or divorce,32916,-0.0119404708021074,0.0205134399167576,-0.0521468130389523,0.0282658714347374,0.560527034862157
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29089.Experienced the death of a spouse or partner,32925,0.0194627535836027,0.0325158160062429,-0.0442682457886334,0.0831937529558389,0.549479514282309
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32912,0.0264231713677658,0.0255008029705018,-0.0235584024544177,0.0764047451899493,0.300150442282855
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29091.Frequency of drinking alcohol,32920,-0.0431280949896528,0.0171466164592349,-0.0767354632497533,-0.00952072672955235,0.0119118344405953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31982,-0.0365476787838897,0.0191405513117815,-0.0740631593549814,0.000967801787202106,0.0562409385648259
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31994,-0.0516968643579371,0.0192056629987898,-0.0893399638355651,-0.0140537648803091,0.00712234639982444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29104.Ever used cannabis,32909,-0.0123411002847057,0.0226144167094654,-0.0566653570352579,0.0319831564658464,0.58527307001249
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29108.Ever thought that life not worth living,32869,0.0135483042034145,0.0208068514474681,-0.027233124633623,0.0543297330404519,0.514968664843672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29109.Ever contemplated self-harm,32881,0.0324417562937293,0.0272306161662049,-0.0209302513920323,0.0858137639794909,0.233539465278768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29111.Ever self-harmed,32900,0.0827908904029017,0.0428591138104266,-0.00121297266553448,0.166794753471338,0.0534279369900117
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32907,-0.00901779336691854,0.0294493551771686,-0.066738529514169,0.0487029427803319,0.759449057399946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,31982,0.050737329111075,0.0931173015944912,-0.131772582014128,0.233247240236278,0.58585416074784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,31982,-0.0446140127872732,0.0744958383828927,-0.190625856017743,0.101397830443197,0.549270103087561
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,31982,-0.00786062988840196,0.0766883386632429,-0.158169773668358,0.142448513891554,0.918361565244315
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,31982,0.0387365413668235,0.103336919861998,-0.163803821562693,0.241276904296341,0.707776797408391
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32897,-0.0314506833264717,0.0191111176794357,-0.0689084739781656,0.00600710732522219,0.0998655249893097
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X29153.Pain or discomfort today,32909,0.00821969499929897,0.018336985284099,-0.0277207961575351,0.044160186156133,0.653977954591385
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29154.Anxiety or depression today,32909,-0.00628468336724137,0.0225137717386086,-0.0504116759749142,0.0378423092404315,0.780137322110884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29166.Frequency of confiding in someone close,32706,-0.000783429851263068,0.0178682840334445,-0.0358052665568143,0.0342384068542881,0.965029172618315
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32881,0.00139209929424057,0.0244968065563891,-0.046621641556282,0.0494058401447631,0.954683637804548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32881,-0.0209968760015219,0.0243993557373874,-0.0688196132468013,0.0268258612437574,0.389508568947736
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32881,-0.0134375305379962,0.0305288024827108,-0.0732739834041093,0.0463989223281168,0.659832418118746
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32881,0.0527536710260056,0.0359686813196098,-0.0177449443604297,0.123252286412441,0.142504600953379
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32881,-0.0922101122056441,0.0557423213095334,-0.20146506197233,0.0170448375610414,0.0981174310353164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32881,0.0196255261367772,0.0262595263101557,-0.0318431454311281,0.0710941977046824,0.454861016698696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32878,0.0147646303897162,0.0285961908605773,-0.0412839036970154,0.0708131644764479,0.60564737156754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32878,-0.00509452816388733,0.0405677128338469,-0.0846072453182272,0.0744181889904525,0.900066515849666
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32878,-0.0401782605687757,0.0652134602513133,-0.16799664266135,0.0876401215237983,0.53784156556556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32878,0.0377186886106864,0.0645439858938628,-0.0887875237412847,0.164224900962658,0.558974356718291
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32878,-0.0526863237014428,0.0861311184475315,-0.221503315858605,0.116130668455719,0.540752307904744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32878,-0.0107427596455108,0.0423887376724872,-0.0938246854835857,0.072339166192564,0.799938409775495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29171.Frequency of feeling 'in tune' with people,32718,-0.0059591314535992,0.0217182829062314,-0.0485269659498128,0.0366087030426144,0.783796569353818
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29172.Freuency of feeling that lacks companionship,32839,0.0171223504211029,0.0199431050257285,-0.0219661354293249,0.0562108362715307,0.390606285769951
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29173.Frequency of feeling left out,32791,0.0167362897155106,0.0205233834862503,-0.0234895419175401,0.0569621213485612,0.414822676242566
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29174.Frequency of feeling isolated from others,32821,0.0142207463283122,0.0211508375757645,-0.0272348953201863,0.0556763879768107,0.501378824175404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29175.Tendency to bounce back quickly after hard times,32894,0.00111572992685136,0.0177545988998292,-0.0336832839168139,0.0359147437705166,0.949893916794588
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29176.Ability to make it through stressful events,32894,0.00372869616303608,0.0174430169926314,-0.0304596171425216,0.0379170094685937,0.83073560903403
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29177.Quick recovery from stressful events,32894,0.00776401670727515,0.0176280735923146,-0.0267870075336615,0.0423150409482118,0.659632781032204
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29178.Hard to snap back when something bad happens,32894,-0.00605314211784947,0.0175226848001918,-0.0403976043262253,0.0282913200905264,0.729767113854138
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29179.Comes through difficult times with little trouble,32894,-0.00179035593272941,0.017749154859146,-0.0365786994566555,0.0329979875911967,0.919655956258389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29180.Tendency to take a long time to get over setbacks,32894,0.00352649209956157,0.01756601661818,-0.0309029004720713,0.0379558846711944,0.840893495388976
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29181.General happiness,32837,0.00269234992741051,0.0183044559369166,-0.033184383708946,0.038569083563767,0.883066551069
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29182.Belief that own life is meaningful,32754,-0.00634783815179258,0.0182131573401695,-0.0420456265385247,0.0293499502349396,0.727450175173589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28170,0.051324643609361,0.025904780167654,0.00055127448075918,0.102098012737963,0.0476232573109479
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2946.Father's age,32519,-0.00155699503558899,0.0175509878977839,-0.0359569313152455,0.0328429412440675,0.929312312886931
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2966.Age high blood pressure diagnosed,28308,-0.00543099621829157,0.0273525254109003,-0.0590419460236561,0.048179953587073,0.842619487481061
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,47194,0.0689473834656492,0.00742726858788248,0.0543899370333996,0.0835048298978989,1.78699145083921e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47194,0.00264641900937121,0.00880111225893901,-0.0146037610181493,0.0198965990368917,0.763652485226855
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30020.Haemoglobin concentration,47194,-0.0583113483142935,0.00937977345976193,-0.0766957042954269,-0.0399269923331601,5.16283956582069e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30030.Haematocrit percentage,47194,-0.0423007248787713,0.00919844061351243,-0.0603296684812557,-0.0242717812762869,4.2739854920994e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30040.Mean corpuscular volume,47194,-0.0512369374248535,0.0074192147495128,-0.0657785983338986,-0.0366952765158084,5.11385428372218e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47193,-0.0596899990159372,0.0074328569770922,-0.0742583986910379,-0.0451215993408365,1.01581560615927e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47193,-0.0336516288120389,0.00729279640649511,-0.0479455097687693,-0.0193577478553085,3.96394323338889e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47194,0.0157299032636543,0.00709436300831019,0.00182495176736631,0.0296348547599423,0.0266163156538839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30080.Platelet count,47194,0.360412569753292,0.0071238064569951,0.346449909097581,0.374375230409002,0
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30090.Platelet crit,47194,0.297925880990445,0.00743486371975456,0.283353548099726,0.312498213881164,0
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47194,-0.207618600581454,0.00709849214765599,-0.22153164519086,-0.193705555972048,1.01451060816653e-184
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30110.Platelet distribution width,47194,-0.092852235703675,0.00715103205659091,-0.106868258534593,-0.0788362128727568,2.03706914451701e-38
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30120.Lymphocyte count,47162,0.0703164775205842,0.00755612752865926,0.0555064675644121,0.0851264874767563,1.44247494503382e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30130.Monocyte count,47162,0.0334879348496132,0.00758056649844768,0.0186300245126557,0.0483458451865707,1.00251007440709e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30140.Neutrophill count,47162,0.0487462522908878,0.00736992629303071,0.0343011967565476,0.063191307825228,3.81630749230132e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30150.Eosinophill count,47162,0.0519146273781114,0.00720426461095078,0.0377942687406479,0.0660349860155749,5.93315003693177e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30160.Basophill count,47162,0.102144732733429,0.0121991215035087,0.0782344545865516,0.126055010880306,5.9232121007492e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30170.Nucleated red blood cell count,47162,-0.0220720816909743,0.0550682270148623,-0.130005806640104,0.0858616432581558,0.688561209008353
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30180.Lymphocyte percentage,47162,0.0126457279253923,0.0074534940944767,-0.00196312049978199,0.0272545763505667,0.0897823700425705
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30190.Monocyte percentage,47162,-0.017896703425717,0.00746531005936103,-0.0325287111420646,-0.00326469570936941,0.0165235200317754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30200.Neutrophill percentage,47162,-0.00946500090553612,0.00733461584244059,-0.0238408479567197,0.00491084614564744,0.196905094625037
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30210.Eosinophill percentage,47162,0.0296832824291695,0.00710818190076818,0.0157512459036639,0.0436153189546752,2.97847350630384e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30220.Basophill percentage,47162,-0.0134160519381454,0.00711211362879807,-0.0273557946505896,0.000523690774298815,0.0592580249939508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47162,-0.0208392690752435,0.0550990780459366,-0.128833462045279,0.0871549238947922,0.705274715994523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30240.Reticulocyte percentage,46767,0.0313316757092869,0.00764094373716427,0.0163554259844449,0.0463079254341289,4.13683788528512e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30250.Reticulocyte count,46767,0.0319477268845228,0.00784126286850029,0.0165788516622622,0.0473166021067834,4.63065645105731e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30260.Mean reticulocyte volume,46767,-0.0440360088390964,0.00737285197703617,-0.0584867987140873,-0.0295852189641055,2.36766483722876e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30270.Mean sphered cell volume,46767,-0.0361321202014097,0.00739555604295885,-0.0506274100456091,-0.0216368303572104,1.03782387184608e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30280.Immature reticulocyte fraction,46767,0.011294571044523,0.00769918378020997,-0.00379582916468857,0.0263849712537345,0.142394432042368
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46767,0.0272890556338046,0.00780893517872469,0.0119835426835042,0.042594568584105,0.00047568074215679
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30300.High light scatter reticulocyte count,46767,0.0270614168152664,0.00794685825944366,0.0114855746267568,0.042637259003776,0.000662053679463594
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30500.Microalbumin in urine,30869,-0.0141137442691858,0.0135583723437204,-0.0406881540628777,0.0124606655245062,0.29792929950204
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47297,-0.00393224614859576,0.00762359147278923,-0.0188744854352627,0.0110099931380711,0.605999181909918
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30520.Potassium in urine,47247,-0.00352305148646241,0.00705864234516644,-0.0173579904829886,0.0103118875100638,0.617705339768814
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30530.Sodium in urine,47247,-0.00218255189892601,0.00734701727026338,-0.0165827057486422,0.0122176019507902,0.766418461755155
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30600.Albumin,44884,0.0557888361260905,0.00790723902975239,0.0402906476277758,0.0712870246244052,1.77434750900523e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30610.Alkaline phosphatase,46835,0.0325935289230958,0.00745141668464044,0.0179887522212005,0.0471983056249911,1.22449288946652e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30620.Alanine aminotransferase,46825,0.0262190177599445,0.00788712689569072,0.0107602490443907,0.0416777864754983,0.000887858614105741
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30630.Apolipoprotein A,44757,-0.0222124458731668,0.00864870472183817,-0.0391639071279696,-0.00526098461836396,0.0102268259743539
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30640.Apolipoprotein B,46684,0.117726172284859,0.00754614314502389,0.102935731720612,0.132516612849106,1.37556834843305e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30650.Aspartate aminotransferase,46761,0.00412897288329714,0.00738401404132572,-0.0103436946377013,0.0186016404042955,0.576046205720862
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30660.Direct bilirubin,43210,-0.066899668021142,0.00807748498587342,-0.0827315385934539,-0.0510677974488301,1.28663937311325e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30670.Urea,46830,-0.0112233479650587,0.00778182204912693,-0.0264757191813475,0.00402902325123011,0.149244946473201
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30680.Calcium,44880,0.0888789448056351,0.00769272836262002,0.0738011972148999,0.10395669239637,8.76688695997048e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30690.Cholesterol,46840,0.123679779348708,0.00775262647785781,0.108484631452107,0.138874927245309,5.4713753757788e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30700.Creatinine,46834,-0.0247645258451941,0.00947630408943927,-0.0433380818604951,-0.00619096982989313,0.00897282016759095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30710.C-reactive protein,46768,0.0118871504198402,0.00808360358954907,-0.00395671261567599,0.0277310134553563,0.141433044739881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30720.Cystatin C,46836,0.00936724525423398,0.00873401121297285,-0.00775141672319281,0.0264859072316608,0.283505841598443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30730.Gamma glutamyltransferase,46831,0.052310438042085,0.00803697775041009,0.0365579616512812,0.0680629144328887,7.73574483258621e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30740.Glucose,44851,0.0150900368785357,0.00786287547451109,-0.000321199051506045,0.0305012728085774,0.0549789057070964
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46667,0.0227707346255548,0.00784295647348186,0.00739853993753037,0.0381429293135793,0.00369564679317673
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30760.HDL cholesterol,44865,-0.0493563901385885,0.00912679643028282,-0.0672449111419428,-0.0314678691352342,6.44803150453283e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30770.IGF-1,46730,-0.00706074179413448,0.00767433938346206,-0.0221024469857201,0.00798096339745116,0.357558660914448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30780.LDL direct,46792,0.121828985358215,0.00765925942097736,0.106816836893099,0.13684113382333,1.15544788573582e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30790.Lipoprotein A,42312,0.00229436780506051,0.00811063220972295,-0.0136024713259965,0.0181912069361175,0.777268959377996
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30810.Phosphate,44830,0.0543616622912748,0.00768260570529669,0.0393037551088933,0.0694195694736563,1.53115272924141e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30830.SHBG,44681,-0.0645405917668271,0.00894851821415237,-0.0820796874665658,-0.0470014960670885,5.68429934242922e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30840.Total bilirubin,46755,-0.0710733350717893,0.00753301505771964,-0.0858380445849198,-0.0563086255586588,4.27418898695667e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30850.Testosterone,45006,-0.0324246689236107,0.0127405102567731,-0.057396069026886,-0.00745326882033549,0.0109346423906725
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30860.Total protein,44868,0.104931960139577,0.00780311069103124,0.0896378631851557,0.120226057093998,4.71225754976678e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30870.Triglycerides,46824,0.174132740334434,0.00764114348359513,0.159156099106587,0.18910938156228,1.07949964124641e-113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30880.Urate,46812,0.0124657542900392,0.00935119645490068,-0.00586259076156612,0.0307940993416446,0.182523649669363
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30890.Vitamin D,45895,-0.040128134263189,0.00808341374040501,-0.0559716251943828,-0.0242846433319952,6.94796749636846e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3137.Number of measurements made,45976,-0.00863561932152548,0.0138364316181707,-0.03575502529314,0.0184837866500891,0.532554002110765
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3143.Ankle spacing width,37444,-0.0218018524060872,0.0134001042994794,-0.0480660568330668,0.00446235202089246,0.103762150541367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37443,0.00366041795580875,0.0102539213318567,-0.0164372678546303,0.0237581037662478,0.721114286373485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3146.Speed of sound through heel,37444,-0.0102927463016964,0.00999544563387075,-0.029883819744083,0.00929832714069031,0.303148710738554
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37444,-0.00584557133492212,0.0100822701243937,-0.0256068207787337,0.0139156781088895,0.562067734692209
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3148.Heel bone mineral density (BMD),37434,-0.00574030164322521,0.0101084629668166,-0.0255528890581857,0.0140722857717352,0.570132046672971
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X3526.Mother's age at death,33640,0.00861876253077857,0.0132720903911009,-0.0173945346357792,0.0346320596973363,0.516101588313214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X3581.Age at menopause (last menstrual period),29423,-0.0260952358444504,0.0184455838399615,-0.062248580170775,0.0100581084818743,0.157208165220151
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29364,-0.0208114982272661,0.0172982851646863,-0.0547161371500513,0.0130931406955191,0.228990908067434
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4100.Ankle spacing width (left),31580,-0.00925535427435561,0.0176371731563906,-0.0438242136608812,0.02531350511217,0.599762299349672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),31580,-0.0115208159160194,0.0134357257434986,-0.0378548383732767,0.0148132065412378,0.391208345281541
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4103.Speed of sound through heel (left),31580,-0.0158613201304789,0.0131422282464629,-0.0416200874935462,0.00989744723258841,0.227508666600521
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",31580,-0.0147575179982916,0.0132510315845732,-0.040729539904055,0.0112145039074718,0.265447630470469
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),31574,-0.0141535757772016,0.0132701033628625,-0.0401629783684122,0.011855826814009,0.286196653636062
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",31580,-0.014777227914946,0.0132511953544451,-0.0407495708096584,0.0111951149797665,0.264815771086525
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4119.Ankle spacing width (right),31569,0.0196618010673913,0.0173589607535694,-0.0143617620096047,0.0536853641443874,0.257392274383809
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),31569,0.00521400929307432,0.0136476390387245,-0.0215353632228258,0.0319633818089744,0.702438678409928
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4122.Speed of sound through heel (right),31569,-0.000683597166067388,0.0132654330420115,-0.02668384592841,0.0253166515962752,0.958902766123629
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",31569,0.00110045710405619,0.0134082233758892,-0.0251796607126865,0.0273805749207989,0.934590557834515
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),31562,0.001769298833543,0.0134334125882492,-0.0245601898394255,0.0280987875065115,0.895218054294731
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",31569,0.00108921210741705,0.0134083039542836,-0.0251910636429788,0.0273694878578129,0.935257854274907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4194.Pulse rate,31844,0.0353620045158663,0.0127880914748032,0.0102973452252521,0.0604266638064806,0.00570134369009758
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4195.Pulse wave reflection index,31844,-0.021372397736081,0.0124528376985278,-0.0457799596251955,0.00303516415303359,0.0861519272132006
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4196.Pulse wave peak to peak time,31839,0.00893933196815168,0.0133224599051237,-0.0171726894458908,0.0350513533821941,0.502241799506824
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4198.Position of the pulse wave peak,31844,-0.00752558396284136,0.0128411832581409,-0.0326943031487976,0.0176431352231149,0.557858035927056
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4199.Position of pulse wave notch,31844,0.0280331588122046,0.012613770156804,0.00331016930486873,0.0527561483195404,0.0262825029581019
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,31844,-0.00521882208981452,0.0131284423541037,-0.0309505691038577,0.0205129249242287,0.690994461229275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4269.Number of triplets attempted (left),31711,-0.0409002498862429,0.0643872149097333,-0.16709919110932,0.0852986913368344,0.525301428294231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4270.Volume level set by participant (left),31632,-0.0414801962545452,0.018999796205389,-0.0787197968171076,-0.00424059569198284,0.0290515242092123
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4276.Number of triplets attempted (right),31722,-0.152842657434017,0.0629337320618388,-0.276192772275221,-0.0294925425928131,0.0151783614676553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4277.Volume level set by participant (right),31635,0.00459917785567127,0.0188178306131874,-0.0322837701461761,0.0414821258575186,0.806923376012719
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X4288.Time to answer,31865,0.0436957733269202,0.014577112177514,0.0151246334589928,0.0722669131948477,0.00272985305277309
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X4290.Duration screen displayed,31865,-0.00948729392029504,0.0128038111115831,-0.0345827636989978,0.0156081758584078,0.45873080769834
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X46.Hand grip strength (left),47896,0.00822165267274469,0.0101473302833025,-0.0116671146825282,0.0281104200280175,0.417817081216557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X47.Hand grip strength (right),47877,0.0133777207794851,0.0100726318373353,-0.00636463762169213,0.0331200791806623,0.184149219619176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X48.Waist circumference,47946,0.0910102330777655,0.0158802469694925,0.0598849490175602,0.122135517137971,1.01011253947144e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X4803.Tinnitus,31669,-0.0336857752313988,0.0234167628280307,-0.079582630374339,0.0122110799115414,0.150323103747257
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X4825.Noisy workplace,31795,0.0306150427158358,0.0254965003365111,-0.0193580979437261,0.0805881833753976,0.229882218783063
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X4836.Loud music exposure frequency,31741,-0.000356031335178761,0.0277437666642536,-0.0547338139971159,0.0540217513267584,0.989761480550106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X49.Hip circumference,47942,-0.0117457960522734,0.0125757475614535,-0.0363942612727223,0.0129026691681754,0.350311295734379
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X50.Standing height,47919,-0.0244412683552858,0.00998644400246369,-0.0440146986001146,-0.00486783811045693,0.0143944222781595
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X5057.Number of older siblings,31124,-0.0181109260862241,0.0197476357284516,-0.0568162921139892,0.020594439941541,0.359110892515891
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X51.Seated height,47803,-0.0103148896120636,0.00926887193662566,-0.0284818786078499,0.0078520993837227,0.265782849071786
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5181.Ever had eye surgery,29276,0.0315303015137888,0.0507733322124406,-0.0679854296225948,0.131046032650172,0.534624959706067
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29265,0.0272199687507057,0.0156713385502129,-0.0034958548077116,0.0579357923091231,0.0824570526303383
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29264,0.0396539463884024,0.015505430759977,0.00926330209884747,0.0700445906779574,0.0105721494757791
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5190.Duration at which refractometer first shown (right),29212,0.0294723119534709,0.0153285719138547,-0.000571688997684443,0.0595163129046262,0.0545701993626774
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5193.Duration at which refractometer first shown (left),29211,0.0304012511689599,0.0153927736971206,0.000231414722603532,0.0605710876153162,0.048315610422643
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5199.logMAR, initial (right)",29241,0.0315131224008182,0.0235658666146908,-0.0146759761639757,0.0777022209656122,0.181202186727241
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5200.Final number of letters displayed (right),29241,0.0723991078234189,0.180728720142642,-0.28182918365616,0.426627399302998,0.688733886075436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5201.logMAR, final (right)",29199,0.0208115566270939,0.0148504256965872,-0.00829527773821697,0.0499183909924047,0.161149195908949
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5202.Number of rounds to result (right),29241,-0.00818050620659178,0.0225143243747295,-0.0523085819810616,0.035947569567878,0.716360189596752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5206.logMAR, initial (left)",29241,-0.00793225241719218,0.0234442424577464,-0.0538829676343751,0.0380184627999908,0.73511609078286
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5207.Final number of letters displayed (left),29241,-0.0080254029546517,0.167596074492337,-0.336513708959632,0.320462903050329,0.961809362932244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5208.logMAR, final (left)",29199,-0.00587698325979204,0.014964119791674,-0.035206658051473,0.0234526915318889,0.694528444145014
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5209.Number of rounds to result (left),29237,0.0251501274166075,0.0225395123036447,-0.0190273166985362,0.0693275715317511,0.264547469822057
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29031,0.0122557455133367,0.0154677610868345,-0.0180610662168589,0.0425725572435322,0.428198059707389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29031,0.0211392993223438,0.0151955323942993,-0.00864394417048289,0.0509225428151704,0.164239108948424
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5256.Corneal hysteresis (right),29031,0.0061043112871075,0.0155506665660777,-0.0243749951824048,0.0365836177566198,0.694672941328907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5257.Corneal resistance factor (right),29031,0.0156146354572073,0.0152377331045089,-0.0142513214276301,0.0454805923420446,0.305536269944442
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29010,0.0184563891127985,0.0155226357435733,-0.0119679769446052,0.0488807551702021,0.234495114521714
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29010,0.00472073596519354,0.0152017440492752,-0.0250746823713858,0.0345161543017729,0.756163594752367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5264.Corneal hysteresis (left),29010,-0.0183654761578294,0.0154698124900453,-0.0486863086383183,0.0119553563226595,0.235210767612693
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5265.Corneal resistance factor (left),29010,-0.0100150020088912,0.0151946655039168,-0.0397965463965681,0.0197665423787858,0.509852658250607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29077,0.05266190733423,0.095026082110747,-0.133589213602834,0.238913028271294,0.579476879156359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47869,-0.0596827553130915,0.0429912261961555,-0.143945558657556,0.0245800480313733,0.165072498492291
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47869,-0.0966384094643604,0.0474258174233197,-0.189593011614067,-0.0036838073146539,0.0415933712734217
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47869,-0.179913139485733,0.117838297215548,-0.410876202028208,0.0510499230567422,0.12682893292459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47869,-0.114736437294571,0.0198849800912507,-0.153710998273422,-0.0757618763157197,8.02433699244646e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47869,0.0990507391734134,0.0178460404641924,0.0640724998635962,0.134028978483231,2.88204573507883e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35842,-0.0162983686059923,0.0202035987637565,-0.055897422182955,0.0233006849709704,0.419851776453053
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35842,-0.105212957918624,0.0704300207005249,-0.243255798491653,0.0328298826544046,0.135237184258592
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35842,0.0116732707714678,0.0345049236940136,-0.0559563796687989,0.0793029212117345,0.735137480654638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35842,0.00457317649355067,0.0218274074084489,-0.0382085420270092,0.0473548950141105,0.834049530302268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47935,-0.0488774167302656,0.0400713399937449,-0.127417243118006,0.0296624096574744,0.222567826692031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47935,-0.0488774167302656,0.0400713399937449,-0.127417243118006,0.0296624096574744,0.222567826692031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47935,-0.0239731385365235,0.029627150241075,-0.0820423530090305,0.0340960759359834,0.418430463038493
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47935,-0.129973687349145,0.0460576514938631,-0.220246684277116,-0.0397006904211729,0.00477675244249633
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47935,0.00877202937954181,0.112846102127261,-0.212406330789889,0.229950389548973,0.938039938007853
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47935,0.0802990803994325,0.0804648655398625,-0.077412056058698,0.238010216857563,0.318318649785578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47935,0.278651429725634,0.120791006125093,0.041901057720451,0.515401801730816,0.0210694602626184
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47868,-0.0297437537665518,0.0228543647267564,-0.0745383086309944,0.0150508010978909,0.193117843229587
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47868,0.0602210219237078,0.0391224855624247,-0.0164590497786446,0.13690109362606,0.123745625859973
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47868,0.0142474106632357,0.0191534685656681,-0.0232933877254738,0.0517882090519451,0.456971251052737
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47868,0.0271363582774264,0.0358322646168344,-0.043094880371569,0.0973675969264217,0.448867816573274
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47868,0.0263893327359546,0.0311886148566416,-0.034740352383063,0.0875190178549722,0.397493845477731
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47868,0.00698503096898339,0.0251841599743439,-0.0423759225807307,0.0563459845186975,0.781507533023735
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29207,-0.13461633112996,0.0654482048469607,-0.262894812630003,-0.0063378496299169,0.0397502535306752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29207,-0.152464724281666,0.056920031147349,-0.26402798533047,-0.0409014632328618,0.00741617660433716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29207,0.0528550154119747,0.0710317600516478,-0.0863672342892549,0.192077265113204,0.456846269125219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29207,0.130335247107941,0.0581912429611814,0.0162804109040259,0.244390083311857,0.0251465168899708
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47830,-0.0551307662432218,0.0629131294454366,-0.178440499956278,0.0681789674698339,0.380875825129068
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47830,0.0447329868847211,0.0918859219469164,-0.135363420131235,0.224829393900677,0.626381998833843
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47830,-0.200267393782159,0.193695515466647,-0.579910604096788,0.179375816532469,0.301179828178397
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47830,-0.0614993744270879,0.154949773068337,-0.365200929641028,0.242202180786853,0.691445644439744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47830,-0.0662668383660917,0.0582162793689876,-0.180370745929307,0.0478370691971239,0.255012005902966
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47830,0.0504397238195143,0.074659955506334,-0.0958937889729003,0.196773236611929,0.49930577029766
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47830,-0.0078039273516347,0.0304224000441642,-0.0674318314381965,0.0518239767349271,0.79755221847446
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32176,-0.0414521434977204,0.0588968469039137,-0.156889963429391,0.0739856764339504,0.481571300740627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32176,-0.082750125453993,0.0648957400227556,-0.209945775898594,0.0444455249906079,0.202300924296503
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32176,0.0540098495947187,0.0835858601183136,-0.109818436237176,0.217838135426613,0.518193492655616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32176,0.0269064523764686,0.0253127860930931,-0.0227066083659939,0.076519513118931,0.287831435822464
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",34023,-0.0902430218612441,0.027993625794601,-0.145110528418662,-0.0353755153038262,0.00126945917942462
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",34023,0.0131276241797348,0.022662175087855,-0.031290238992461,0.0575454873519305,0.562416687679836
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",34023,0.0364266795423319,0.0224141511589332,-0.00750505672917726,0.080358415813841,0.104158550739834
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",34024,-0.078372891400491,0.0545116796449575,-0.185215783504608,0.0284700007036258,0.150542430537628
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",34024,0.0250951192195253,0.0353547500480464,-0.0442001908746456,0.0943904293136963,0.477838880303585
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",34024,-0.0167881834670852,0.0444511243941566,-0.103912387279632,0.0703360203454618,0.705678171915886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47868,-0.0251381593095394,0.0530689578174021,-0.129153316631648,0.0788769980125688,0.635726304958255
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47868,-0.0122085238945417,0.034472376218647,-0.0797743812830899,0.0553573334940065,0.723226716357401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47868,-0.249992736732272,0.105855057593692,-0.457468649615909,-0.0425168238486358,0.0182016830349689
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47868,-0.0627707080177915,0.0390550127392037,-0.139318532986631,0.0137771169510478,0.108015277587867
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47868,-0.0276547169860272,0.0431442929129841,-0.112217531095476,0.0569080971234216,0.521540468614683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47868,-0.0764640990465716,0.0469329337749912,-0.168452649245554,0.0155244511524111,0.103279463028609
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47868,0.0054835448945615,0.0153288741863034,-0.0245610485105933,0.0355281382997163,0.720551125592015
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27518,-0.0508460530013938,0.0501949442667056,-0.149228143764137,0.0475360377613492,0.311140722579009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27518,-0.0341370046966745,0.0642396743904578,-0.160046766501972,0.0917727571086226,0.595173437056374
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27518,-0.00366414060711349,0.0474718818924879,-0.0967090291163898,0.0893807479021628,0.938480203401936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27518,-0.0491809747326814,0.0397162146074233,-0.127024755363231,0.0286628058978682,0.215680702467239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47982,0.052192986730737,0.0164198254835113,0.020010128783055,0.0843758446784191,0.00148146040106778
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47982,0.0853644122148792,0.0480596994985306,-0.00883259880224076,0.179561423231999,0.0757099069520904
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47982,-0.0121988707585909,0.0165511345781907,-0.0446390945318447,0.020241353014663,0.461104365449929
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47982,-0.0270191440272914,0.0161003337639317,-0.0585757982045977,0.00453751015001478,0.0933263016242533
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47982,0.0422653659995259,0.0233935078075619,-0.00358590930329551,0.0881166413023473,0.0708194202356246
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47982,-0.00914800846580279,0.0238328371042375,-0.0558603691901083,0.0375643522585027,0.701100040456913
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47982,-0.019584270798935,0.0178060095886918,-0.0544840495927709,0.0153155079949009,0.27140035475821
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47982,-0.00975553913153129,0.0498204097466234,-0.107403542234913,0.0878924639718505,0.844757316064042
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40175,-0.011151074607526,0.0175666934421277,-0.0455817937540962,0.0232796445390443,0.525577507734772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40175,-0.00513511548533742,0.0184533242103155,-0.0413036309375557,0.0310333999668809,0.7808040978209
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40175,0.0232615739111441,0.0220122728863596,-0.0198824809461207,0.066405628768409,0.290639178066843
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40176,-0.0048593441710425,0.0303332783118745,-0.0643125696623166,0.0545938813202316,0.87272673343406
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40176,0.0142534353630434,0.0195181018111159,-0.0240020441867439,0.0525089149128306,0.46523717642729
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47777,0.0105968194944671,0.0181996469133226,-0.0250744884556451,0.0462681274445794,0.560401009125496
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47777,0.0146796948311758,0.0142879711882763,-0.0133247286978457,0.0426841183601973,0.304234858675074
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47777,0.0182443071944363,0.0170365316788509,-0.0151472948961114,0.0516359092849841,0.284228226708219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47777,0.0278825134697304,0.0264931463308491,-0.0240440533387339,0.0798090802781947,0.292607205650696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47792,0.031897096658102,0.0156362439153252,0.00125005858406461,0.0625441347321393,0.0413666388964618
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47792,-0.0184404910238595,0.0216355926977015,-0.0608462527113545,0.0239652706636355,0.394043943722584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47868,0.0220679684737274,0.0165520930411474,-0.0103741338869214,0.0545100708343763,0.182464598014924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47868,0.0144312633543373,0.0204682396485624,-0.025686486356845,0.0545490130655195,0.480781978250893
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47868,-0.0255472942495545,0.0303895854312577,-0.0851108816948196,0.0340162931957105,0.40054707742287
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47868,0.0421073118963309,0.035939700510868,-0.0283345011049705,0.112549124897632,0.241365305295376
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47868,0.0232187888738661,0.0350270090059813,-0.0454341487778572,0.0918717265255895,0.507412218760589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47868,-0.00591333196111891,0.050765344018056,-0.105413406236509,0.0935867423142708,0.907270227019774
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37444,-0.00585666105015042,0.0100823428828812,-0.0256180531005976,0.0139047310002967,0.561328982854114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X864.Number of days or week walked 10+ minutes,47533,-0.00184300649942766,0.0108366402781378,-0.0230828214445778,0.0193968084457225,0.864955154806178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X874.Duration of walks,44388,-0.0115609786566872,0.00746237709245505,-0.0261872377578991,0.00306528044452469,0.121340561484116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46891,0.0195346846500687,0.0105616346173045,-0.0011661191998482,0.0402354884999856,0.0643855960022128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X894.Duration of moderate activity,41682,0.00350107383190468,0.0125906329832818,-0.0211765668153276,0.028178714479137,0.78096206261716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29161,0.0161014363413983,0.015626409456936,-0.0145263261941962,0.0467291988769927,0.302869762226838
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46909,0.00139659594397027,0.0107288647690931,-0.0196319790034522,0.0224251708913928,0.896431618815366
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X914.Duration of vigorous activity,37421,-0.00318779035417497,0.00963054195694712,-0.0220636525897913,0.0156880718814414,0.740643249404145
